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ABSTRACT
Glutamic Acid Resorcinarene-Based Molecules and Their Application in
Developing New Stationary Phases in Ion Chromatography
Tayyebeh Panahi
Department of Chemistry and Biochemistry, BYU
Doctor of Philosophy
Resorcinarenes can be functionalized at their upper and lower rims. In this work, the
upper rim of a resorcinarene was functionalized with glutamic acids and the lower rim was
functionalized with either methyl or undecyl alkyl groups. The cavitands were characterized by
nuclear magnetic resonance (NMR), mass spectrometry (MS), UV-vis spectroscopy, dynamic
light scattering (DLS) and electron microscopy. The binding of resorcinarene with amine guests
was studied in DMSO by UV-vis titration. The obtained binding constants (K values) were in the
range of 12,000-136000 M-1. The resorcinarenes were shown to form aggregates in a variety of
solvents. The aggregates were spherical as confirmed by DLS, SEM and TEM experiments.
Dynamic light scattering (DLS) experiments revealed the size of the aggregates could be
controlled by cavitand concentration, pH, and temperature.
The resorcinarene with undecyl alkyl group were adsorbed onto 55% cross-linked
styrene-divinylbenzene resin to prepare a new stationary phases for ion chromatography (IC)
columns. The new column packing material was applied in determination of uremic toxins and
water contaminants. The new IC column afforded separation of the five uremic toxins :
guanidinoacetic acid, guanidine, methylguanidine, creatinine, and guanidinobenzoic acid in 30
minutes. Detection and quantification of uremic toxins helps diagnose kidney problems and start
patient care. Gradient elutions at ambient temperature with methanesulfonic acid (MSA) as
eluent resulted in detection levels in water from 10 to 47 ppb and in synthetic urine from 28 to
180 ppb. Trace levels of creatinine (1 ppt) were detected in the urine of a healthy individual
using the columns.
The new IC stationary phase separated cationic pharmaceuticals including a group of
guanidine compounds in surface water. Detection limits in the range of 5 - 32 μg L-1 were
achieved using integrated pulsed amperometric detection (IPAD) for guanidine (G),
methylguanidine (MG), 1,1-dimethylbiguanidine (DMG), agmatine (AGM), guanidinobenzoic
acid (GBA) and cimetidine (CIM). Suppressed conductivity (CD) and UV-vis detection resulted
in limits of detection similar to IPAD, in the range of 1.7 - 66 μg L-1, but were not able to detect
all of the analytes. Three water sources, river, lake, and marsh, were analyzed and despite matrix
effects, sensitivity for guanidine compounds was in the 100 μg L-1 range and apparent recoveries
were 80-96 %. The peak area precision was 0.01 - 2.89% for IPAD, CD and UV-vis detection.
Keywords: resorcinarene, binding constant, aggregates, ion chromatography, uremic toxins,
detection limit, guanidines, separation
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Chapter 1 Resorcinarene-Based Molecules and Their Application to Ion
Chromatography
Abstract
The synthesis of resorcinarene-base molecules and their application in ion
chromatography techniques are reviewed in this chapter. Macrocyclic resorcinarene molecules
are synthesized by condensation of resorcinol (1,3-dihydroxybenzene) and different aldehydes.
Resorcinarenes can be modified with various substituents on their upper and lower rims to
provide specific functionality and selectivity. These various derivatives have applications in
supramolecular recognition, nanoscale reaction containment, catalysis, chiral NMR shift agents,
and chromatographic separations, as well as drug encapsulation, protection, and delivery. The
stationary phase of different separation techniques such as HPLC, GC, and IC can be modified
by resorcinarene derivatives. Two classes of IC columns including cation and anion exchange
were designed and applied in separation of transition metals, biological compounds and
pharmaceuticals. Electrochemical and conductivity detectors have been used widely in analysis
of pharmaceutical and biological compounds with IC. The broad applications of resorcinarenebased molecules show that they are a promising class of compounds. Therefore, synthesis and
their separation applications are explored.
Keyword: Resorcinarene; Derivatives; Separation; Ion chromatography; Detectors.

1. Introduction
A resorcinarene is a macrocyclic molecule that arises from the condensation of resorcinol
(1,3-dihydroxybenzene) and various aldehydes.1 Resorcinarenes have been used industrially
since the 1930s, when the products of resorcinol-aldehyde condensation reactions were found to
1

enhance the resistance of adhesives and paste.2 Later, in the 1940s, Niederl and Vogel published
several studies using elemental analysis techniques on the condensation reaction between
aliphatic aldehydes and resorcinol, which resulted in the proposed cyclic tetrameric structure in
Figure 1 (Rl = alkyl).3 Full characterization of the resorcinarene molecule was accomplished by
Högberg and coworkers later in the 1980s using X-ray crystallography and NMR
spectroscopy.1,4 In 1982, Cram and his coworkers, gave the name cavitand to this class of the
compounds5; this name came from the concave cavity shape of the molecule, which was
sufficiently large to accommodate other molecules and ions.
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Figure 1 (a) Structure of the first synthesized resorcinarene3; molecular models of
resorcinarene (b) side view; (c) top view. R1 = alkyl.

Hydroxyl groups on the upper rim of the resorcinarenes make them vulnerable to
electrophilic aromatic substitution reactions. In addition, the adjustable ring size and changeable
lower rim have assisted chemists in designing a wide range of resorcinarene derivatives. These
various derivatives have applications in supramolecular recognition, nanoscale reaction
2

containment, catalysis, chiral NMR shift agents, and chromatographic separations, as well as
drug encapsulation, protection, and delivery.6–11
Most of the earliest cavitands were shallow, bowl-shaped structures and prepared from
resorcinarenes through alkylation, silylation, or a one-step derivatization with the aryl group of
the phenolic hydroxyls.12–14 These cavitands were limited by their dimensions (ca. 9.0 Å wide
and 3.0 Å deep) and were only able to interact with small molecules. However, due to the
simplicity of their synthesis, they have been used extensively in many areas. For example, a
shallow water-soluble cavitand was used (Figure 2, a and b) as an efficient catalyst for the
hydrolysis of esters of phosphate acids15 (a) and inverse phase-transfer16 (b). The phase-transfer
catalyst can carry out the Mannich-type reactions in water without the need for any added
surfactants or organic solvents.16 The resorcinarene derivative can afterward be recovered in
aqueous solution and recycled after the simple extraction of the water-insoluble products.

HO3S
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OH

CH3 4

4
a

SO3Na

b

Figure 2 Water-soluble calixarene sulfonic acid. Shallow resorcinarene cavitand as an
efficient catalyst for the hydrolysis of esters of phosphate acids15 (a) and inverse phasetransfer16 (b).
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There is a wide range of applications for shallow resorcinarenes with different functional
groups on the upper rim or lower rim; we have limited this text to more recent applications. For
instance, a recent report showed the application of a newly synthesized resorcinarene (tetra‐
methoxy resorcinarene tetra‐hydrazide ) as a reducing and capping agent for the synthesis of
water‐dispersible stable palladium nanoparticles.17 These derivatives of resorcinarene hydrazide
function as reducing and stabilizing agents.
Another type of shallow cavitand with interesting applications was introduced by Wenzel
et al.11,18,19 They synthesized a water-soluble shallow cavitand with a chiral functional group on
the upper rim and a sulfonic group on the lower rim (the presence of an ionic group on the lower
rim assists in enhancing the polarity of the cavitand in aqueous conditions). Using these shallow
cavitand derivatives, they conducted successful studies in chiral recognition. The introduction of
chirality to resorcinarene cavitands opened a new and important path in the separation of small,
hydrophobic chiral molecules, which we describe later in more detail.
Later work built up the rims of the resorcinarene and deepened the cavities (a depth of
∼8.0 Å). Deeper cavitands are capable of housing more sizable guests and have been extensively

applied in host-guest studies. One method of synthesizing a deeper cavitand has been through the
condensation of the resorcinarene hydroxyl groups with a 6,7-disubstituted-2,3dichloroquinoxaline.20 An alternative method involves the use of a simpler building block in the
bridging reaction followed by extension of the rim through heterocyclic synthesis. The cavitands
in Figure 3 (a) are usually prepared by bridging the resorcinarene hydroxyl groups with a
preformed heterocycle, e.g., condensation with a 6,7- disubstituted-2,3-dichloroquinoxaline.
Even later, a deeper cavitand (Figure 3(b)) was introduced, obtained by reaction of
octanitrocavitand with phenylenediamine units and condensation with 1,2-diketones. The
4

resulting fused pyrazines provide the deepened cavities. Acenaphthenequinone formed another
type of deep cavitand, which was also utilized to construct helicates and extended surfaces.21,22
(Figure 3 (c))

Figure 3 The structure of deepened cavitands, a: bridging with 6,7- disubstituted-2,3dichloroquinoxaline, b) elongated with a reaction of octanitrocavitand with
phenylenediamine units and condensed with 1,2-diketones c) bridging with
acenaphthenequinone.21,22

Recently, another type of a deep cavitand with two major components, the resorcinarene
scaffold and the quinoxoline panels, was introduced by our group.23 The upper rim of a new
resorcinarene molecule was elongated with four identical substituents of alanine and glycine
groups, and the lower rim functionalized with methyl or undecyl alkyl chains. (Figure 4)
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Figure 4 Alanine and glycine derivativatized resorcinarene molecule with methyl and
undecyl chains at the lower rim.23

Another class of deep cavitand consists of capsules created by covalent or non-covalent
binding between two or more resorcinarenes.24–26 Encapsulation enables rigorous control of the
environment and housing of molecules isolated from solvent at ambient temperatures in the
liquid phase. In either conformation (cavitands or capsules) molecules in the confined space
respond to the size, shape and chemical environment of the container. This provides a unique
way for separation of small to large molecules from the solvent environment.
As mentioned earlier, introducing chirality to resorcinarene derivatives has been
investigated by scientists during recent years. Chirality in resorcinarene derivatives is rare;
however, it has been achieved by two primary methods. The first method, inherent chirality,
refers to resorcinarene molecules with all achiral substituent groups in their structure.27–29 One of
the earliest C4-symmetric inherently chiral resorcinarenes was obtained by substitution of one of
the hydroxyl groups at each ring with a methoxy group to separate the enantiomers. Theses chiral
hosts were shown to discriminate between enantiomeric guests (Figure 5).30

6

Figure 5 Inherently chiral C4-symmetric resorcinarenes.30

The second method involves the attachment of one or more enantiomerically chiral
groups to the molecule; this is the focus of our study.23,31–33 Chiral groups are introduced on the
upper rim or through substitution at the aryl hydrogen atom between the two hydroxyl groups of
the resorcinarene bowl. Enantiomerically-pure groups have been bonded to shallow and deep
cavitands to provide chirality and both cases showed successful chiral discrimination in reported
research.31-33
One recent report on introducing chirality to shallow cavitands involves using eight
fluorenylmethoxycarbonyl (Fmoc) derivatized alanine units surrounding the opening of the
cavity. (Figure 6) The binding of pinanediol as a guest molecule was demonstrated with 1H
NMR, and the cavitand was shown to undergo a slow exchange of bound and unbound forms in
acetone-d6. Their studies showed the preference of chiral cavitand to bind to (-)-pinanediol rather
than (+)-pinanediol, and the 1H chemical shifts of the bound enantiomers were considerably
different.32
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Figure 6 Chiral shallow cavitand and (-)-pinanediol. Chiral cavitand prefers to bind to (-)pinanediol rather than (+)-pinanediol.32 (Et = ethyl)

Another class of shallow cavitands with chiral functional groups on the upper rim was
designed by Wenzel et al.34 They introduced water-soluble shallow chiral cavitands, which have
been widely used in chiral recognition among enantiomers (Figure 7). The sulfonate moiety on
the bridging groups at the lower rim accounts for the water solubility. Chirality was achieved by
binding L-proline (a), cis-4-hydroxy-D- (b), and -L-proline (c), trans-4- hydroxy-L-proline (d),
and trans-3-hydroxy-L-proline (e) to the resorcinol rings. This water-soluble resorcinarene
derivative was used as a chiral NMR solvating agent for a variety of compounds.
Optically pure chiral solvating agents are often used in NMR spectroscopy for the
analysis of enantiomeric purity. Association of the enantiomers with the chiral solvating agent
can involve noncovalent interactions such as hydrogen bonding, dipole-dipole interactions, and
π-stacking between electron-rich and electron-deficient aromatic rings. Introducing a watersoluble chiral resorcinarene has opened a new path in the separation of small, hydrophobic chiral
molecules. The affinity of the hydrophobic cavity enhances the binding and the successful
separation of enantiomers in an aqueous environment.
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Figure 7 Water-soluble sulfonated calix[4]resorcinarenes derivatives. Chirality was
achieved by bonding L-proline (a), cis-4-hydroxy-D-(b), and -L-proline (c), trans-4hydroxy-L-proline (d), and trans-3-hydroxy-L-proline (e) to the resorcinol rings.34

Chirality on deeper cavitands has been achieved by bonding different enantiomerically
pure compounds. Introduction of a chiral moiety through phthalimide units bridged through the
hydroxyl groups of the resorcinol rings is another popular method in developing chiral
resorcinarenes. Rebek et al. have studied a resorcinarene derivative with a deepened cavity in
which phthalimide units bind through the hydroxyl groups of the resorcinol rings.33 They
successfully showed the enantiomeric differentiation of racemic trans-1,2-cyclohexanediol in mxylene-d10.
Our group used a similar method in the elongation of a resorcinarene molecule using
phthalimide units to form a deep cavitand.23 This cavitand was functionalized with
enantiomerically pure alanine groups to introduce chirality. The presence of four carboxylic
acids on the upper rim provides a potential binding site for amine groups. (Figure 4) A series of
chiral amines containing a benzyl ring were chosen for binding studies. The chiral amines were
9

added to the acidified derivatives of the resorcinarene molecule and the signal of the amines was
monitored. The changes in the chemical shift of the amines indicated the binding of chiral
amines to the host molecule (resorcinarene derivatives).
Based on the polarimetry of the complexes, chiral recognition was reported for different
substituents of the resorcinarene molecule. The amine substrates undergo rapid exchange and
their resonances become deshielded in mixtures with the cavitand. The absence of significant
shielding indicates that amine substrates are not encapsulated deep in the cavity. Instead, they
undergo a neutralization reaction with the carboxylic acid group of the alanine and associate
through dipole–dipole interactions. These newly designed deep resorcinarene molecules were
characterized with different techniques such as nuclear magnetic resonance (NMR), mass
spectrometry (MS), and the sustained off-resonance irradiation collision-induced dissociation
(SORI-CID) technique in FTICR-MS.

2. Application of Resorcinarenes in Chromatography Techniques
The application of resorcinarenes in separation fields encompasses techniques such as
high performance liquid chromatography (HPLC), gas chromatography (GC), electrokinetic
chromatography (EKC), capillary electrophoresis (CE), and ion chromatography (IC) for the
separation of a variety of organic and inorganic species.

2.1 High Performance Liquid Chromatography (HPLC)
Resorcinarenes have been applied to both the mobile phase and the stationary phase of
HPLC.35–40 Lipkowski et al. in 1998 used resorcinarene complexes in the mobile phase of reverse
phase HPLC.41 They showed the host–guest complexation of tetraalkylcalix[4] resorcinarene (the
upper rim was modified with phosphoryl, sulfonyl and dialkylaminomethyl derivatives) with
10

some aromatic guests in the mobile phase. The formation of the inclusion complexes resulted in
changes in the retention of aromatic guests and improved their separation.
In another example, application of resorcinarenes in HPLC techniques was reported by
Pietraszkiewicz et al. in 1998, in which the RP-18 stationary phase was modified with
calix[4]resorcinarene (Figure 8).35 The lower rim of the resorcinarene molecule was derivatized
with long alkyl chains, which provide enough hydrophobicity to attach to the hydrophobic
surface of the resin; the resorcinarene derivative binds to the resin through hydrophobic
interactions. The coated resin showed good separation of three pyrimidine bases including
cytosine, uracil, and thymine.
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Figure 8 C-tetra-n-undecylcalix[4]resorcinarene coated RP-18 stationary phase.35
In 2005, Alexander Ruderisch et al. synthesized a novel silica-bonded stationary phase
that was bonded covalently to a resorcinarene derivative (Figure 9).38 They proposed a
straightforward method to attach the resorcinarene to the surface of silica particles: The upper
rim of the resorcinarene was modified with isopropyl isocyanate to form a polar interaction site,
and the lower rim had long alkyl chains each containing a terminal double bond. The
resorcinarene was then immobilized on the silica resin by a free radical-induced reaction on
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mercaptopropyl-functionalized silica. The new stationary phase had improved hydrolytic
stability under high aqueous conditions, higher efficiency for separation of polar analytes, and
higher selectivity to low molecular weight acids.
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Figure 9 Synthetic pathway towards the silica-bonded and polar functionalized
resorcinarene in RP-type stationary phase.38

More recently, in 2011, Huey Min Tan et al. showed the application of resorcinarene
derivatives in the preparation of chiral stationary phases in HPLCs.39 They synthesized two types
of stationary phase, on which they immobilized two different derivatives of resorcinarene
molecules. (Figure 10)
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Figure 10 (3-(methylcalix[4]resorcinarene)-2-hydroxypropoxy)-propylsilyl-appended silica
particles (MCR-HPS) [a] and bromoacetate-substituted MCR-HPS particles (BAMCRHPS) [b] have been synthesized and used as chiral stationary phases for high-performance
liquid chromatography (HPLC).39

Two newly developed stationary phases were studied for separation of several disubstituted benzenes and some chiral drug compounds. They examined both columns for
separation of positional isomers of nitrophenol, using mixtures of methanol/water for the
separation of isomers on both columns, and investigated the effect of methanol percentage on the
separation efficiency.
Both columns were also applied to chiral separation. The BAMCR-HPS-packed column
showed better chiral recognition; however, the separation efficiency was greatly influenced by
the percentage of methanol. The optimum enantioseparation of 1-phenyl-1-propanol is shown in
Figure 11using 4:1 MeOH/H2O.
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Figure 11 Enantioseparation of 1-phenyl-1-propanol on the BAMCR-HPS-packed column;
the composition of mobile phase was MeOH/H2O.39

In studies in 2014, Chamseddin et al. investigated calixarene- and resorcinarene-bonded
stationary phases using modeling software.42 They conducted a systematic evaluation of the
applicability of DryLab (Molnár Institute, Berlin, Germany) to these types of stationary phases in
the presence of conventional alkyl-bonded phases. Three types of resorcinarene-bounded
stationary phases were modeled, including substituted benzene derivatives, 4-hydroxybenzoic
acid esters and polycyclic aromatic hydrocarbons (Figure 12).
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Figure 12 Resorcinarene derivatives attach to the silica stationary phase. Representative
structures of stationary phases, a: calixarene A (AI: n = 4; AII: n = 6; AIII: n = 8), b:
calixarene B (BI: n = 4; BII: n = 6; BIII: n = 8), c: resorcinarene (n = 4); and d: synergy
polar-RP chromatographic.42

Three different mixtures of model analytes, consisting of alkyl-substituted benzene
derivatives, 4-hydroxybenzoic acid esters, and polycyclic aromatic hydrocarbons, were used to
verify the accuracy of DryLab prediction of retention times, as well as to compare the results of
20 different liquid chromatographic phases. The results showed that the prediction on the
calixarene- and resorcinarene-bonded stationary phases as well as on other reversed-phase
columns is highly accurate in both isocratic and gradient modes. As a result, DryLab could be
applied with very accurate predictions in method development using calixarene- and
resorcinarene-bonded stationary phases, which were used as an example for “new” stationary
phase materials.

2.2 Gas Chromatography (GC) and Capillary Electrophoresis (CE)
The recent application of resorcinarene derivatives in GC systems has been reviewed in
brief.43–47 One of the earliest works goes back to Zhang et al. in 1997.43 They synthesized a
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resorcinarene derivative in which the lower rim was modified with pentane groups and the upper
rim with phenyl groups (Figure 13). The ligand successfully coated onto a fused-silica capillary
column. According to their TGA analysis, the newly designed stationary phase was thermostable
to 240 °C and suitable for GC use.
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Figure 13 The structure of resorcinarene derivative stationary phase.43

Later, chiral resorcinarene derivatives were also introduced into GC stationary phases.
Ruderisch et al. introduced an enantiomerically pure resorcinarene as a chiral stationary phase in
an enantioselective capillary GC.44 The upper rim of the resorcinarene molecule was derivatized
with the chiral amino acid valine to impose chirality through a series of reactions. The presence
of unsaturated functions in the long alkyl groups on the lower rim allowed the attachment of the
chiral resorcinarene to a polysiloxane of the stationary phase through a catalytic reaction (Figure
14). This type of GC column successfully separated several proteinogenic D,L N(O,S)-TFA
amino acid methyl esters, as shown in Figure 15.
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Figure 14 Structure of chiral resorcinarene derivative coated the silica-fused column in
capillary GC.44

Figure 15 Gas chromatographic separation of enantiomers of 16 N(O)-trifluoroacetyl-DLamino acid ethyl esters on a 20 m × 0.25 mm fused-silica column coated with ChirasilCalixval-Dex (film thickness 0.25 µm). Temperature program: 70 °C (3 min); 3 °C/min; 170
°C; carrier gas: 0.5 bar hydrogen; split: 1:100.44
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Due to the ability of resorcinarenes to form reversible complexes with charged and
uncharged analytes, some applications of these molecules were investigated with electrophoretic
methods.48–53 Resorcinarene incorporation in capillary electrophoresis (CE) helps to improve the
separation of neutral species. Resorcinarenes can develop a pseudo-stationary phase in CE to
improve the interactions between neutral analytes and the stationary phase for better column
efficiency.
Although the presence of resorcinarenes assists in achieving better separation of neutral
analytes, their use is limited by the high UV-absorbance of the resorcinarene derivatives; a
stronger baseline noise was observed in most investigations. Therefore, other detectors, such as
electrochemical detectors, or noncovalent or covalent bonding of the resorcinarenes to the
capillary wall were used to overcome these problems. Different varieties of resorcinarene
derivatives have been used in CE methods, such as resorcinarene with sulfonic, carboxylic, or
substituted ammonium groups. These media have been used to separate positional isomers,
amines, polycyclic aromatic hydrocarbons, and organic anions.

2.3 Ion Chromatography (IC)
Our group has developed new stationary phases using resorcinarenes for IC techniques.
One phase was based on a resorcinarene molecule that was modified with cyclen groups on the
upper rim; and undecyl chains on its lower rim.54,55 Stationary phases were made by adsorbing
N-undecyl cyclen and cyclen–resorcinarene (cyclenbowl) onto resin (Figure 16). Research
showed that the column loaded with cyclen-resorcinarene gave significantly better performance.
In addition to the investigation of this column’s ability to separate common anions, this
column was examined for pre-concentration of anions. The column was operated under basic
18

conditions. According to the pKa of cyclen (10.6), at a lower pH, the cyclen column will be
protonated; at a higher pH, it will remain neutral. Therefore, the pH of the eluent adjusted the
capacity of the cyclen column. Sodium bicarbonate and sodium hydroxide were used in a
multistep gradient for pre-concentration of perrhenate and perchlorate ions. Figure 17 shows a
separation and pre-concentration of perrhenate from six other anions.
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Figure 16 Structure of N-undecyl cyclen and cyclenbowl molecules.56

Figure 17 Pre-concentration of perrhenate on cyclen bowl column by step gradient. Peaks:
1 = F-, 2 = Cl-, 3 = NO2- , 4 = NO3-, 5 = SO42- & PO43-, 6 = ReO4-. A step gradient from 10
mM NaHCO3 (pH 7.6–8.0) to 10 mM NaOH (pH 12) was used to accomplish the
separation.56
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A year later, in 2012, Li et al. used cyclen derivative stationary phases for the separation
and pre-concentration of cations.56 The binding strength was compared for different transition
metal ions and a high binding constant of cyclen for Cu2+ was discovered. The separations were
done under acidic conditions. Due to the pKa of the cyclen group and protonation of cyclen sites
on the stationary phase, the column could be used as a cation exchange column. A multi-step
gradient with nitric and oxalic acids was used for the separation of six cations, which is shown in
Figure 18.

Figure 18 Separation of transition metal ions with gradient elution on the cyclenbowl
column. Eluent: 2 mM oxalic acid for 10 minutes before injection; after injection, eluent
step change: 0 - 10 min, 1 mM oxalic acid + 10 mM HNO3; 10 – 32 min, 50 mM HNO3.
Peaks: 1 = Mn2+ (0.6 mg L-1); 2 = Cd2+ (0.8 mg L-1); 3 = Co2+ (0.2 mg L-1); 4 = Zn2+ (0.2 mg
L-1); 5 = Ni2+ (0.6 mg L-1); 6 = system peak. Flow rate: 0.35 mL/min.56

This column showed a significant selectivity for Cu2+ in the presence of high
concentrations of matrix ions such as Mn2+, Co2+, Ni2+, Cd2+, and Zn2+. The pre-concentration
experiment successfully separated and pre-concentrated parts per billion levels of Cu2+ with a
multi-step gradient using low and high concentrations of nitric acid. In order to pre-concentrate
the Cu2+, first a low concentration of HNO3 (5 mM) was used to elute the mixture of Mn2+, Co2+,
20

Ni2+, Cd2+, and Zn2+ while Cu2+ in the sample was bound more strongly to the stationary phase of
the column. Several injections of 2 mL of analyte were made to the column consecutively.
Second, higher concentrations of nitric acid (up to 50 mM) were used to elute the Cu2+ from the
stationary phase (Figure 19).

Figure 19 Preconcentration of Cu2+ using HNO3 as eluent. Mixture of analytes: Mn2+, Co2+,
Ni2+, Cd2+, Zn2+ (1 mg L-1 each), and 15 μg L-1 Cu2+. Eluent flow rate: 1.0 mL/min.56

Li et al. also introduced a new type of resorcinarene derivative in our group.23 They
synthesized a new resorcinarene molecule in which the upper rim was elongated with four
identical substituents of alanine and glycine groups (Figure 4). The newly designed deep
cavitand was applied to ion chromatography. These molecules adsorbed onto a 55% cross-linked
styrene-divinylbenzene resin in preparation of an IC column. The presence of carboxylic acids
on the upper rim creates cation exchange sites for IC stationary phases. They successfully used
this column for the separation of six metal ions (Mn2+, Co2+, Ni2+, Cd2+, Cu2+, and Zn2+). The
pKa value of the AUA ligand was determined by pH titration and resulted in 5.19 ± 0.08 at the
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95% confidence interval. Therefore, at a lower pH, the newly packed stationary state performed
as cation exchange sites.57
To choose the appropriate acidic eluents, a group of acids were selected, including nitric
acid (HNO3), oxalic acid, dipicolinic acid (PDCA), succinic acid, and citric acid. The separation
of six metals was studied using HNO3. Lower concentrations of HNO3 (up to 5mM) was eluted
all of the metal ions except Cu2+, which showed stronger retention to the stationary phase.
Higher concentrations of HNO3 (up to 10 mM) helped the elution of Cu2+ from the column.
According to their studies, HNO3 was selected as the most suitable eluent due to a shorter
separation time and higher resolution. The separation of all six metal ions is shown in Figure 20.
The UV-vis absorbance method was used for the detection of metal ions by recording
dual wavelengths at 520 nm and 620nm. Detection of transition metals was assisted by using a 4(2-pyridylazo) resorcinol (PAR) solution. This solution was used as a post-column reagent with
the ability to bind to the metal ion analytes. The method was very sensitive for all the ions, but
particularly for Cu2+ and Mn2+.
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Figure 20 Separation of six transition metal ions with oxalic acid gradient on AUA column.
Conditions: 10 mM HNO3 for 10 minutes before injecting analyte, after injection, 0-24 min,
1.5 mM oxalic acid; 24-40 min, 15 mM oxalic acid. Peaks: 1 = Cu2+ (1.28 ppm); 2 = Ni2+
(1.28 ppm); 3 = Zn2+ (1.28 ppm); 4 = Co2+ (1.28 ppm); 5 = Mn2+ (0.32 ppm); 6 = Cd2+ (1.28
ppm).57

3. Ion Chromatography
3.1 Principles and applications
Ion chromatography (IC) has been growing in popularity since 1975 when it was
introduced by Small et al.58 This type of analysis is useful for the separation of ions, as the name
suggests. IC separates compounds based on their ionic potential or electrostatic interactions with
other molecules. Generally, the smaller compounds have a greater charge to size ratio and are
less attracted to the column material; therefore, they interact with the column less and elute from
the column more quickly. This trend might be different from traditional HPLC, which separates
compounds based on their polarity. After Lee and his team in the late 1980s introduced high
performance anion exchange chromatography (HPAEC) with pulsed amperometric detection
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(PAD) for the analysis of mono and oligosaccharides, ion chromatography has been widely used
in the biotechnology industry and academic research.59
Today, different kinds of IC are widely used in biological research.60 The most
predominant forms of IC are ion exchange chromatography, ion exclusion chromatography and
ion paired chromatography. In ion exchange chromatography (IC), the analyte enters the mobile
phase and is carried to the stationary phase, which has a charge opposite to the analyte. The
analyte forms ionic bonds with the stationary phase and then is replaced or exchanged by the
ions in the eluent. Two general trends are observed in ion exchange chromatography. The first
trend is that the smaller the ion, the faster it elutes from the column. The second trend is that
more polar compounds elute faster from the column than nonpolar compounds, due to their
attraction to the mobile phase. The potential for the molecule to make ionic interaction with the
stationary phase also plays a large role in the elution order of compounds. Nitrite will elute
before nitrate because of the size of the molecule, but also because the nitrate has more oxygen
atoms that can create ionic interaction with stationary phase.
Variations in the chemical nature of the ion-exchange functional group play an important
role in the selectivity of ion exchange chromatography. Generally, two types of columns are
involved in separating ionic species in ion exchange chromatography: anion exchange and cation
exchange columns. A large number of excellent columns for anion and cation exchange
chromatography are now available commercially. Dionex Ion Pac hydroxide-selective and
carbonated-base columns are anion exchange columns that consist of a polymeric spherical
material coated with an outside layer of functionalized latex.
Ion exclusion chromatography (IEC) is a form of chromatography that has been used to
separate relatively small weak acids (carbonic acid, carboxylic acids, hydrocarboxylic acids,
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etc.), weak bases (ammonia, amines), and hydrophilic molecular species such as carbohydrates,
glycols, and alcohols. Ion exclusion chromatography has a stationary phase with the same charge
as the analyte, which is the opposite of ion exchange chromatography. The separation in IEC is
based more on molecular species than ionic charge. This is a relatively old technique, which was
introduced by Wheaton and Bauman for the first time.61 Substances that can be separated with
IEC are weak organic and inorganic acids, as well as hydrophilic neutral compounds such as
sugars. The mechanism for ion exclusion chromatography is still not clear; however, the trend
observed is that less polar compounds elute from the column later than polar compounds, which
is the same trend as ion exchange chromatography. The separator in IEC is similar to the
exchangers used in ion exchange chromatography. Weak acid analytes are separated with
sulfonated cation exchangers or polyacrylate resins with carboxylic acid functional groups; gel
exchangers with quaternary ammonium are used to separate weak bases. The main difference
with ion exchange chromatography is the column capacity, which is generally higher for ion
exclusion chromatography.
Ion pair chromatography (IPC) can separate ions on the standard reverse-phase columns
used for HPLC; this separation is accomplished by adding an ionic reagent to the mobile phase to
pair with sample ions of opposite charge. In this chromatography, separation of different ions is
based on differences in ion pair retention time on the stationary phase. The common ion pair for
anionic samples is liphophilic cations, such as tetrapropylanions, and for cationic species are
sulfonated alkyl groups (C6-C10), as well as certain inorganic anions such as perchlorate or
hexafluorophosphate.
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3.2 Mobile phase and column selection
The separation mechanism of IC is based on ionic interactions; therefore, the eluent type
and pH can affect the separation efficiency of columns. For ionic species, changing the pH will
have little effect on the ionic state as long as the species is fully ionized (cations or anions).
However, for polar basic compounds such as amines, a decrease in the pH of the mobile phase
will cause an increase in the analyte cationic species. This is due to the protonation of basic ionic
species under low pH. On a cation exchange column, the retention times of such compounds
under low pH are expected to increase. This phenomenon can occur when the mobile phase pH is
close to the pKb (pKb = 14 – pKa) of the analyte; otherwise, when the mobile phase pH is
significantly lower than the pKb of the analytes, the retention time will decrease. The decrease in
retention time of the analytes comes from increasing the mobile phase concentration and
increasing the protonation of anionic functional groups in the stationary phase. Anion exchange
chromatography will follow the same scenario using alkaline pH instead of acidic pH. Therefore,
to achieve the optimum separation, it is necessary to evaluate the effect of the mobile phase pH
on the analyte characterization, peak resolution and column capacity. Due to the hydrophobicity
of some drug molecules and their strong interaction with the polymeric stationary phase of IC
columns, adding organic solvents and choosing a column with lower hydrophobic resin
characteristics will result in shorter retention times and better peak shape (symmetrical and near
symmetrical).

3.3 Detection Techniques in Ion Chromatography
A variety of detectors can be used for detection and quantification of analytes in IC.
Detectors need to be selected according to the nature of the analyte molecules. The common
detectors in IC include the universal refractive index (RI), UV detector (for analytes that absorb
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UV), fluorescence detector (for analytes that contain fluorophores), or radio- chemical detectors.
Traditionally, IC techniques were incorporated with electrochemical detection methods that
included conductivity (suppressed and non-suppressed) and pulsed amperometry techniques.
In this chapter, the newer detection systems in IC are discussed. As was mentioned
previously, the type of detector selected depends upon the nature of the analytes and therefore,
based on our work, the electrochemical detection mechanism and techniques are under review. It
is not intended to suggest that other detectors should not be used with IC.
3.3.1 Conductivity Detection
The principle of conductivity detection is based on the generation of current due to
passing ionic species between electrodes. When voltage is applied to the electrodes, the ionic
species in solution can produce current. The intensity of this current is proportional to the
conductivity of the solution, which depends upon the concentration of ions and polar molecules.
The presence of any ionic species between the electrodes can generate current, and includes
eluent ionic species, which can provide the background (baseline) conductivity. A problem
occurs, however, when the conductance of the eluent is significantly stronger than that of the
analytes. The concentrations of ions in eluents are normally 104-105 times higher than analyte
concentrations. This was one of the limitations of conductivity detection, which has led to the
invention of suppressors.
3.3.1.1 Suppressed and Unsuppressed Conductivity Detectors
Today, suppressors are commonly associated with ion chromatography, and have become
an integral part of the IC systems. The role of suppressor is to remove the eluent ionic species
before they reach the detector. The suppression process decreases the intensity of the eluent
conductivity by converting the ionic species to weakly dissociated species, while enhancing the
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analyte signals by converting the analyte ions to fully dissociated species. Consequently, this
leads to the overall enhancement of the signal to noise ratio for conductivity detection. Small et
al. first introduced the concept of suppressed IC.58 Their suppressor was a packed column that
was termed a stripper column. The column material was in hydroxide form to change the eluents
chemically before they reached the conductivity detector. His designed suppressor converted
mineral acids to water, reducing background signal and noise significantly. Meanwhile, the
analyte species was converted to its base form, which was fully dissociated and carried more
charge. This enhanced the sensitivity of the detection. To obtain a better vision of suppression,
the eluent containing HA (A- being the anion) was passed through the suppressor, where the
exchange of A- for OH- to produce water could occure. This eliminated the background noise
signal, and consequently provided a more stable baseline and improved the analyte sensitivity.
Some unsuppressed methods have also been offered by researchers; for instance, in 1979 Gjerde
et al. used IC without any suppressor.62 They used dilute solutions of acids and bases to avoid a
large background signal.
The non-suppressed detection method has some significant limitations in practical
application. In the suppressed method, the eluent passing through the detector is essentially pure
water with approximately zero conductivity, but in the non-suppressed method, the acidic and
basic eluents pass through the detector. The presence of strong acid or base at the conductivity
detector can generate baseline noise of 1000-1500 µS. Therefore, it is necessary to use dilute
weak acid and base eluents in the non-suppressed method because they are only slightly
dissociated. Another limitation of the non-suppressed methods is having to use a low-capacity
ion-exchange column; there is no limitation on column capacity for suppressed methods. This is
due to the ability of suppressed methods to use fairly concentrated acid and base eluents.
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In addition, the signal to noise ratio reported for the suppressed method is about an order
of magnitude better than the non-suppressed systems. Due to this fact, the limit of detection and
limit of quantification are more than an order of magnitude better than in non-suppressed
methods. The present suppressor mechanism is based on electrical suppression. To explain the
mechanism of operation of electrolytic suppressors, we present the operation of anion
suppression techniques in Figure 21.

Figure 21 A Schematic diagram explaining the mechanism of ion suppression of an effluent
from an anion-exchange column by an electrolytic suppressor. This image is from the book
“Application of Ion Chromatography for Pharmaceutical and Biological Products” by
Lokesh Bhattacharyya and Jeffrey S. Rohrer.63
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3.3.2 Pulse Amperometric Detection
The first commercial electrochemical (EC) detector was introduced in 1974 for HPLC
systems.64 Since then, this type of detector has become popular with different types of
chromatography systems. High sensitivity, high selectivity, and a wide linear range are the
reasons for the successful widespread use of this type of detector. In addition, EC detectors are
relatively inexpensive, simple to construct, and rugged. The ability to miniaturize easily is
another advantage of this kind of detector.
When EC detectors and high efficiency separation techniques are combined, they can be
applied to relatively complex samples.65 Some early works with EC detectors dealt with
biological compounds and drugs. These samples were able to undergo oxidation and, less
commonly, reduction. Most of these samples were aromatic in nature (e.g., phenols,
aminophenols, catecholamines, and other metabolic amines). The oxidation of such compounds
happened readily at the surface of noble metals or inert electrodes (e.g., Au, Pt, and carbon) by
applying a constant potential. This constant potential method is called DC amperometry. The
presence of the aromatic ring with extended conjugation stabilizes the free radical intermediates
formed during the anodic oxidation process. Therefore, the activation energy is lowered
significantly. The electrode’s role is to accept or donate electrons in the detection process, which
is the reason for using inert metals for the electrode. Electrode deactivation is the result of
electrochemical involvement (i.e., adsorption of reactant and/or products) in the detection
process. One reason for the popularity of glassy carbons in EC methods is their resistance to
fouling in dc amperometry. It is important to note that the electrode’s exposure to analyte is
much less than its exposure to the eluent. Therefore, the fouling and deactivation process often
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occurs over a period of hours or days. In dc amperometry, mechanical polishing is required to
reactivate the electrode surface.
Alternative methods include the application of alternate positive and negative potential
pulses at the surface of the electrode; pulse potential waveforms have been used extensively to
reactivate fouled noble metal electrodes. Because radical intermediates in polar aliphatic
molecules (e.g., carbohydrates and biogenic amines) do not self-stabilize and have a slow
oxidation process, stabilizing the reaction intermediates by adsorption at “clean” noble metal
electrodes can increase the efficiency of oxidation. This means that the deactivation or fouling of
the working electrode dramatically increases, and causes complete passivation within seconds.
This phenomenon is the reason for the non-reactivity of polar aliphatic organic compounds
observed in the past. Addressing this problem required continuous reactivation or cleaning the
surface of the electrode on-line, which only electrochemical reactivation methods can
accomplish effectively.
Today’s electrochemical systems perform at high pH. Oxidation occurs by the application
of pulses of positive potentials. The generated current is proportional to the analyte
concentration, which can be detected and quantified. To prevent electrode fouling, a series of
potential pulses at fixed times are applied that clean the electrode surface. The basis of pulsed
amperometry detection (PAD) is a repeated series of potentials (E1, E2, E3…) over defined time
periods (t1, t2, t3…). The series of potentials is called a waveform. The original waveform applied
to Au and Pt electrodes was a three-step potential-time waveform. The initial part of the
waveform is Edet; detection occurs at this potential during the time period tdet. At the same time,
sampling of the faradaic signal takes place over the time period tint after a delay of tdel to
overcome capacitance currents. The average of the current (amperes or coulombs per second) is
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the output signal. Eoxd (an oxidative cleaning potential) occurs at toxd and is followed by
reductive reactivation at Ered during the period tred. The total final waveform cycle (ttotal = tdet +
toxd + tred) is ca. 1 s with a frequency of ca. 1 Hz, as shown in Figure 22.

Figure 22 The waveforms known as PAD as translated to cyclic voltammetric response.
This image is from the book “Application of Ion Chromatography for Pharmaceutical and
Biological Products” by Lokesh Bhattacharyya and Jeffrey S. Rohrer.63

Integrated pulse amperometry detection (IPAD) is the latest advancement in
electrochemical waveforms. IPAD differs from PAD in that the signal current integrates through
a rapid cyclic scan during the detection potential step within a pulsed potential time waveform.
IPAD can easily diminish the baseline offset and drift that occurs in PAD due to small variations
in the mobile phase, changes in the total surface area of the noble-metal electrode, and analyteinduced effects. At high pH, analytes are oxidized at the surface of the gold electrode by
applying pulses of potentials. Among detectable compounds, numerous amines can be oxidized
and detected directly at gold electrodes in alkaline solutions. The presence of a non-bonded
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electron pair on the nitrogen atom of the amines facilitates the adsorption process at the electrode
surface. This helps in the detection of primary, secondary and tertiary amines, but not quaternary
amines.
Based on previous research, the detection of amines is best performed using an IPAD
waveform. For example, Draisic et al used cation-exchange chromatography with IPAD to detect
biogenic amines (i.e., putrescine, histidine, cadaverine, histamine, and spermidine) in spoiled
canned herring.66 Using electrochemical detection greatly improved amino acid detection. Anion
exchange columns were used for the separation of amino acids with a quaternary gradient that
incorporated both a pH and organic modifier gradient. The IPAD detection method has been
used for detection of amino acids, with recent studies showing typical detection limits of 1–50
pmol with electrochemical detection systems. (Figure 23)
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Figure 23 HPAEC-PED results for a mixture of seventeen amino acids (AA S-18 standard
from Sigma) at 500 pmol each. Run conditions can be found in Technical Note 50 (2001)
from Dionex (Sunnyvale, CA). 66

4. Application of IC in Pharmaceutical and Biological Compounds
4.1 IC determination of pharmaceutical ingredients
Ion chromatography has been widely used in determination of active pharmaceutical
ingredients (API). 67–69 API are the components of a pharmaceutical product that combat disease
or bacteria, and are commonly termed the active ingredients. Quantification of API can be
especially difficult because pharmaceutical products contain cations, anions, and neutral
compounds, which cannot be simultaneously separated. The application of IC in analysis of API
provided precision, accuracy, and reproducibility consistent with current industry practice, and
led to the further application of IC for analysis in the pharmaceutical area.
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However, the disadvantages of applying IC universally in the pharmaceutical field
remained a serious matter for pharmaceutical scientists. Many drugs do not have enough stability
to be assayed under the acidic and basic conditions normally used in IC. Another problem is that
some drugs contain a hydrophobic motif in their structure, which can attach to the IC column
material. The elution of such compounds requires using organic solvents, and the suppressor and
electrochemical detection systems do not perform well in organic solvents.
In contrast, normal- and reversed-phase chromatographies showed greater utility in
relatively high concentrations of organic solvents. This eliminated the problem of hydrophobic
compounds sticking to the column materials. The ease with which mass spectrometers can be
used with reversed-phase chromatography resulted in strong interest in applying these techniques
in the pharmaceutical industry. Therefore, the application of IC has been limited to ionic or very
polar molecules such as aminoglycoside antibiotics and bisphosphonates.
However, the popularity of IC applications in the pharmaceutical industry has been
increasing due to the introduction of new types of pharmaceutical drugs (new molecular entities),
the presence of counter ions in the structures of pharmaceutical molecules (to improve stabilities
and solubility properties of pharmaceutically active drug molecules), the development of
detection systems with a higher tolerance to organic solvents, and the availability of mixed mode
columns. Another important reason for the growing popularity of IC is the use of dilute acidic
and basic eluents modified with little to no organic solvent. Such eluents can be disposed of
easily after neutralization or dilution. Organic solvents cost more, and their disposal is often
more complex, expensive, and environmentally unfriendly. One example is acetonitrile, a
common solvent in reversed-phase chromatography.

35

One of the ionic groups of pharmaceuticals is the guanidine class of compounds.70–72
Recent research shows that the level of some guanidine derivatives in surface waters is elevated.
There may be no immediate effect of small doses of these pharmaceuticals in humans, but there
is concern that long-term, low-level exposure could be harmful. For example, a recent report
describes the effect of long-term exposure to cimetidine on zebrafish and other freshwater fish.
Cimetidine is a histamine H (2)-receptor antagonist that inhibits stomach acid production.
Endocrine disruption resulted from long-term exposure to cimetidine levels as low as 30 mgL-1.
The ultimate excretion of drugs to urine is the apparent source of such contaminants in surface
water. These contaminants are called “contaminants of emerging concern” by the EPA, and there
is a growing need to be able to detect and remove them.
The most common analytical methods for detecting such drugs are chromatography
techniques, which have several advantages over enzymatic and spectrochemical methods.
Pharmaceutical compounds tend to lack suitable chromophores for detection by UV absorbance,
and cannot be detected by this means unless the concentration is high. The use of derivatizing
reagents in the form of post or pre- column reagents is a common way to detect these
compounds, although derivatization has limitations. Our group was the first to report the
combination method IC-ED as the most effective detector of these compounds in surface water.
Three methods of detection, electrochemical (IPAD), conductivity detection (CD), and UV-vis,
were tested; IPAD was found to work best for all of the guanidine derivative compounds, and
UV-vis was very sensitive for cimetidine.73
One of the most important classes of antibiotics is the aminoglycosides such as amikacin,
gentamicin, kanamycin, neomycin, and others. They lack suitable chromophores for detection by
UV absorbance and cannot be detected by this means unless the concentration is high. One of the
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earliest works in the detection of aminoglycosides occurred in 1994.74 Kaine and Wolnik used
anion exchange chromatography equipped with pulsed electrochemical detection and a NaOH
eluent to separate gentamicin in formulations. Since then, scientists have introduced different
methods using ion exchangers for the preliminary extraction of aminoglycoside antibiotic
components.
Rohrer and Hanko applied a newly developed method in the determination of tobramycin
( class of antibiotics) and its impurities.75 They used CarboPac PA1 (4mm × 250 mm) and its
guard (4mm × 50mm) columns with a weak potassium hydroxide eluent (2.00 mM) at a column
temperature of 30 °C. Due to the lack of chromophoric groups in this family of antibiotics,
detection by UV absorbance usually requires high concentrations, and studies show that
refractive index detection suffers the same problem. Derivatization with different groups leads to
decreased efficiency in detection and causes instability in some reagents. The introduction of
pulsed amperometric detection (PAD) provided a nearly complete solution. Detection was
performed with an AAA-Direct waveform using a disposable electrode replaced over 7 days.
This method was later replaced by conventional EP using a waveform consisting of 3 potential
pulsed amperometric waveforms: detection at 0.05 V, oxidative cleaning at +0.75 V, and ending
with gold oxide reduction at -0.15 V. Carbohydrate determination had been attempted using the
same waveform in earlier studies, but gold loss from the working electrode resulted in losing
peak area response over a shorter time of use. The introduction of a 4-potential program that
replaced reductive cleaning by oxidative cleaning was able to maintain the gold working
electrode for a longer time of use.
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Fig 1.25 Determination of 21 pmol tobramycin (1.07 M, 20L injection) using a CarboPac
PA1 column with a 2.00mM KOH eluent (produced by an eluent generator) at 0.5 mL/min,
a 30 ◦C column temperature, and IPAD. Full view (A), and expanded view of baseline (B).
Peaks 1, 2, and 6: unknown impurities; Peak 3: kanamycin B; Peak 4: neamine; Peak 5:
tobramycin; Peak 7: oxygen dip from the previous injection.75
Furthermore, IC has been widely applied in analysis of phosphonates, a class of drugs
used to treat diseases such as hypercalcemia and osteoporosis, and also to prevent the loss of
bone mass. 76–79 The phosphonate drugs are water-soluble and ionic, with very low solubility in
organic solvents, which makes them very well suited for IC analysis. Phosphonates suffer from
the lack of strong chromophore groups in their structures and therefore a very high concentration
of the compound is needed to be detected by UV-vis detectors. Additionally, their volatility is
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not sufficient for gas chromatography. Another important limitation is the high tendency of
phosphonates to chelate metal ions; therefore, a metal-free system is required for analysis.
Commercial IC systems are metal-free and frequently use dilute acids, alkalis, or salt solutions as
eluents. The eluent solution also contains nitric acid, which permits the indirect detection of
phosphonates with UV detectors. Some methods have been reported that used derivatizing
reagents in the form of a post column reactor to assist with UV detection. Both suppressed and
non-suppressed conductivity detection of phosphonates have been reported as well.76-79

4.2 IC Determination of Biological Compounds
IC has been applied in biological product analysis to measure buffer ions, ionic
impurities, monosaccharides, oligosaccharides, and small repeating saccharide units of
polysaccharides in vaccines, hematologic products, and allergenic extracts.
One small group of biological products that has been analyzed with different LC
techniques consists of the uremic toxins.80 Uremic toxins resulting from chronic kidney disease
(CKD) range from small water-soluble molecules to large proteins; abnormally high levels of
these molecules are toxic. One study found that the levels of some guanidine compounds
increased greatly in the serum and cerebrospinal fluid of uremic patients, while the levels of
other uremic toxins were unchanged or even decreased. Chromatography is the most common
technique for measuring uremic toxins. HPLC is used regularly for analysis of these molecules.
Several detection methods have been developed for use with HPLC. The lack of strong
chromophoric groups in some of the uremic toxins required either a high concentration of analyte
for detection by UV-vis, or the use of derivatizing reagents combined with reverse-phase HPLC.
In some cases, mass spectrometry can assist in enhancing the detection limit.81,82
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One subgroup of uremic toxins consists of very polar molecules containing a guanidine
unit. Although they are polar and water-soluble, there are only a few examples in which ion
chromatography (IC) has been applied to their separation. One of the earliest works relates to the
application of IC columns in conjunction with HPLC to pre-concentrate or separate polar
compounds.83,84 Different types of IC columns, such as a strong cation-exchanger (RSO3-), weak
cation-exchanger (RCOO-) and a reversed-phase column, were compared in the determination of
uremic toxins.85 The weak cation exchange method was preferable due to simplicity, less matrix
interference, and higher success in determining the analyte. A recent study used a Dionex CS14
(4 × 250 mm) cation exchange column and a guard column (4 × 50 mm).86 The authors analyzed
guanidine in a high salt and protein matrix with UV-vis. Introducing ED alleviated the need for
derivatization and improved the detection limit significantly.
In our group, we have reported a new IC packing material that effectively separates
uremic toxins in aqueous media and urine by a straightforward method. The new IC column
allowed separation of the five guanidine compounds. Gradient elution at ambient temperature
with methanesulfonic acid (MSA) solution as the eluent resulted in detection levels in water from
10 to 47 ppb and in synthetic urine from 28 to 180 ppb. Limits of quantification for the analytes
using pulsed amperometric detection were 30 to 160 ppb in water and 93 to 590 ppb in urine.
Trace levels of creatinine (1 ppt) were detected in the urine of a healthy individual using the
columns.87
Vaccines is another class of biological compounds which have been studied by IC-PAD.
For example, IC-PAD has been widely adopted for the determination of saccharide content as a
measure of product characterization and potency determination in bacterial capsular
polysaccharide (PS) vaccines.63 The measurement of PS content was originally performed using
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the orcinol colorimetric assay to quantify the ribose moiety.63 Tsai et al. were the first to report
the combination of IC-PAD to quantify PS in Haemophilus influenzae type b PS and
glycoconjugate vaccines using methodologies that had been previously reported for natural
glycoconjugate proteins.88

Conclusion
Resorcinarene-based cavitands are synthesized from the condensation of resorcinol and
various aldehydes. Resorcinarenes having structures easily functionalized with polar, cationic
and anionic groups, have achieved excellent separations of some species. The attachment of one
or more chiral groups introduce chirality to the resorcinarene derivatives and aid their application
in chiral recognition and chiral NMR shift agents. Resorcinarene derivatives have been applied
in both the mobile phase and the stationary phase of different chromatography techniques. Our
group has developed new stationary phases using resorcinarene derivatives in IC techniques. The
resorcinarene derivatives were applied as cation exchange and anion exchange sites in IC for
separation of transition metals, pharmaceuticals and biological compounds. Different detection
techniques including IPAD, CD and UV-vis were applied in our recent studies in IC. The recent
application of IC in the analysis of pharmaceuticals and biological compounds exhibit the
potential of such techniques for further innovations and studies.
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Chapter 2 Resorcinarene-Based Cavitands with Glutamic Acid Substituents
and their Ability to Bind Amines
Abstract
Resorcinarene-based deep cavitands including glutamic acid methyl resorcinarene
(GMA) and glutamic acid undecyl resorcinarene (GUA) have been synthesized. The upper rim
of the cavitands is functionalized with glutamic acid groups and the lower rim is functionalized
with either a methyl or undecyl alkyl group. The cavitands were characterized by nuclear
magnetic resonance (NMR), mass spectrometry (MS), UV-vis spectroscopy, dynamic light
scattering (DLS) and electron microscopy. The GMA and GUA cavitands form kite-like
structures in dimethylsulfoxide, acetone, and water. The ester derivative (GUE) showed vaselike structure in benzene and kite-like structure in DMSO, acetone and chloroform. The binding
of GMA with amine guests was studied in DMSO by UV-vis titration and compared to that of
phthalyl glutamic acid. The obtained binding constants (K values) were in the range of 12,000136000 M-1. The binding constants for GMA to guanidine compounds were measured and found
to be from 4300-153,000 M-1. The ester and acid derivatives of the cavitands were shown to form
aggregates in a variety of solvents. The aggregates were spherical as confirmed by DLS, SEM
and TEM experiments. Dynamic light scattering (DLS) experiments revealed that the size of the
aggregates could be controlled by cavitand concentration, pH, and temperature. For example,
1×10-4 M GMA gave 50 nm diameter particles and 0.1 M cavitand gave particles of 400 nm.
Keywords: resorcinarene; characterization; binding constant; UV-vis titration; aggregation.

49

1. Introduction
A one of the traditional families of molecules in supramolecular chemistry,
resorcinarenes have a highly interesting multipurpose scaffold.1–3 Applications of these
molecules range from the formation of capsules, coordination cages, and molecular loops, to
applications in supramolecular sensors and phase-transfer catalysts. Resorcinarenes and the
similar calixarenes with their bowl-shaped structure are at the center of a number of significant
host-guest studies.4–11
The ability of resorcinarene molecules to be decorated at both their upper and lower rims
provides them with unique properties and advantages over other host molecules. These
molecules are synthesized by condensation of resorcinol (1,3-dihydroxybenzene) and various
aldehydes. Varying the nature of the substituent group on the aldehyde facilitates the preparation
of resorcinarenes with different solubility properties.1,3
Chirality in resorcinarene derivatives is rare, yet has been achieved by two primary
methods. First, inherent chirality, which refers to resorcinarene molecules with achiral
substituents that create a chiral molecule due to their arrangement or twist.12,13 Second,
attachment of one or more enantiomerically chiral groups to the molecule.4,14–18 The chiral
cavitands bind to enantioactive guest molecules through non-covalent interactions. The chirality
of the cavitand along with its size, shape and surface characteristics controls the selective
binding between two enantiomeric guests.
The most common methods to evaluate binding of guests by resorcinarenes are 1H NMR
and UV-vis studies. One component (guest) is incrementally added to the system (host) while
monitoring a physical property such as a specific chemical resonance (NMR) or absorption band
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(UV) that is sensitive to the supramolecular interaction of interest. The resulting data are fitted to
binding models to obtain association constants Ka. 19
Recognition and selective binding by macrocyclic compounds has been achieved recently
for the separation of pharmaceuticals and for enantioselective catalysis. One example of chiral
resorcinarenes is their use as catalyst for the addition reaction of diethylzinc to benzaldehyde.
The chiral resorcinarene was synthesized by the Mannich reaction between resorcinarene
tetratosylate, diamine and excess paraformaldehyde, which resulted in a bridged dimethoxy ketal
diamine ligand. This structure showed enantioselectivity for (R)-1-phenyl propyl alcohol (ee
51%).18
Chiral NMR solvating agents based on resorcinarene have been introduced for green
chemistry applications and analysis of enantiomeric purity. Association of the enantiomers with
the chiral resorcinarene solvating agent involved noncovalent interactions such as hydrogen
bonding, other dipole-dipole interactions, and π-stacking between electron-rich and electrondeficient aromatic rings. This leads to different chemical shifts of enantiomers in the NMR
spectrum and thus can be used to examine enantiomeric purity. For example, chiral
resorcinarenes were synthesized by bonding enantiomerically chiral proline groups or pipecolinic
acid derivatives to the upper rim of resorcinarenes.14,20,21 Different types of guest molecules,
including neutral and protonated primary amines, amino acids, and amino alcohols were shown
to bind to the hosts. This cavitands demonstrated chiral discrimination for pyridyl, phenyl, and
bicyclic aromatic substrates.
Introduction of chiral moieties through phthalimide units bridged to the hydroxyl groups
of the resorcinol rings is a fruitful method to develop chiral resorcinarenes.22,23 These hosts were
shown to discriminate between enantiomeric guests. Guest molecules, including racemic trans51

1,2-cyclohexanediol were encapsulated in the resorcinarene cavities. The large shielding in the
1

H NMR spectra was used as evidence of binding and enatioselectivity of 33% ee for trans-1,2-

cyclohexanediol was achieved.24 Arm elongation was also achieved by using Fmoc-protected
chiral alanine chlorides at the upper rim of the resorcinarene to provide a deep chiral pocket. A
racemic mixture of (+)- and (−)-pinanediol underwent a slow exchange of bound and unbound
forms in d6-acetone and substantial shielding of the substrates. The complexation of (-)pinanediol was favored.25
Our group has investigated resorcinarenes with chiral phthalimide units on their upper
rim.15 We have observed chiral recognition of benzyl amines which is important class of guests
amenable to study. The 1H NMR titration experiments with chiral primary, secondary, and
tertiary amines showed that this cavitand causes different chemical shift changes for these three
types of amines. Also. it shows chiral discrimination for secondary amines at greater than two
equivalents. A vast majority of drugs are amines or contain functional groups derived from
amines. Studies show that stereoisomers of racemic drugs often differ in pharmacological
activity; thus assessment of their optical purity is critical.26,27 Chiral resorcinarenes can bind to
alkyl ammonium cations in solution or gas phase.28,29 For example, we showed a chiral
resorcinarene with alanine moieties on the phthalimide unit performed chiral recognition of
amines such as 1-phenylethylamine, N-methyl-1- phenylethylamine and N,N-dimethyl-1phenylethylamine.15 Enantiomeric differentiation was achieved in d6-DMSO. The protonation of
the amines enhanced the interaction between the host anion and guest cation as a mimic of the
molecular recognition features of naturally occurring proteins for small molecules.
In addition to chiral recognition by one host molecule, aggregates of deep cavitands have
also been used for chiral recognition to selectively bind guest molecules.30 Some resorcinarenes
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form micelles and bilayer structures, mimicking biological membranes. The presence of both
hydrophilic and hydrophobic parts within one cavitand structure makes this possible.31–33 The
acid chloride (2, 5, 8, 11, 14 pentaoxaheptadecan-17-oyl chloride) was used to modify the upper
rim of an octaamino cavitand with long alkyl groups on the lower rim.34 The cavitand formed
vesicles and a bilayer structure in water, which was revealed by TEM measurements. Guest
complexation was essentially driven by the hydrophobic effect in aqueous media. The
complexation of guests depended on their size and hydrophilic properties.
In this chapter, we report the design and synthesis of deep chiral cavitands with glutamic
acid groups on the upper rim and methyl or undecyl alkyls on the lower rim. The glutamic acids
on the upper rim enrich the resorcinarene with eight carboxylic acids, which can enhance the
interaction with guests through hydrogen binding. The binding of the resorcinarenes with amines
and guanidine compounds is presented. Binding constant were calculated and chiral selectivity
observed. The amphiphilic properties of these resorcinarenes caused the formation of spherical
particles, as confirmed with DLS, TEM and SEM studies. The formation of these particles and
their size were controlled by factors such as concentration, pH, and temperature.

2. Experimental
2.1 General Methods
All the chemicals were obtained from Sigma-Aldrich., unless otherwise noted.
Deuterated NMR solvents were used as supplied from Cambridge Isotope Laboratories. The
methyl and undecyl resorcinarenes were synthesized according to literature procedures.1,15
Compounds quinoxaline-2,3-diol (Q) , 2,3-dichloroquinoxaline (Cl-Q), 5,6-dichloropyrazine2,3-dicarboxylic acid (Cl-Py-COOH), 2,3-dichlorofuro[3,4-b]pyrazine-5,7-dione (Cl-Py-CO),
53

and phthalyl glutamic acid (PGA) were synthesized according to published methods.15,35
Acronyms: Q = quinoxaline, Py = pyrazine, G = glutamic acid, M = methyl, U = undecyl, E =
ester and A = acid of the glutamic acid.
VXR 500-MHz multinuclear FT-NMR was used to record 1H and 13C NMR spectra. The
proton chemical shifts (1H) were reported in parts per million (δ) with respect to
tetramethylsilane (TMS, δ = 0 ppm) or solvent peaks. Mass spectrometry was equipped with a
micro-electrospray ionization (ESI) source with a heated metal capillary drying tube and was
modified based on the design of Eyler. The typical operating flow rate of the ESI source was 10
μL·h-1. The matrix-assisted laser desorption/ionization (MALDI) instrument used to measure the
mass of GEM and GEU was an API QSTAR pulsar I from AB Applied Biosystems MDS
SCIEX. The applied matrix was alpha-cyano-4-hydroxycinnamic acid (alpha-CHC matrix)
obtained from Agilent Technology. The Zetasizer nano ZS dynamic light scattering instrument
(Malvern instrument, Malvern, Worcestershire, UK) was used to analyze the particle size
distribution of the compounds. The transmission electron microscopy (TEM) instrument was a
FEI Tecnai F30. Scanning electron microscopy (SEM) was performed with a FEI Helios
NanoLab 600 DualBeam FIB/SEM. Sputter coating was used to apply an ultra-thin coating of
gold metal on the SEM samples. Melting points were determined using a SRS DigiMelt MPA
160 apparatus from Stanford Research Systems, Inc. Optical rotations were measured using a
Perkin-Elmer 241 polarimeter (sodium D-line, 529 nm) and D values are given in 10-1 deg cm2 g1

. Elemental analyses were performed by M-H-W Laboratories, Phoenix, AZ. Simultaneous

thermogravimetry – differential scanning calorimetry (STA/TG-DSC) was performed with
Netzsch STA 409 PC.
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2.2 Synthesis
Dimethyl 2-(2,3-dichloro-5,7-dioxo-5,7-dihydro-6H-pyrrolo[3,4-b]pyrazin-6yl)pentanedioate (GPy). 5,6-Dichloropyrazine-2,3-dicarboxylic acid anhydride (0.4360 g, 2.00
mmol) and L-glutamic dimethyl ester (0.761 g, 4.34 mmol) were put in a closed heavy walled
glass container. 2.0 mL of acetic anhydride was added to the mixture and the reaction was stirred
at 120 °C for 6 h. The reaction mixture was cooled to room temperature and poured into 20 mL
of distilled water and extracted with 20 mL dichloromethane (CH2Cl2). The extraction was
repeated 3 times with CH2Cl2 and the collected solution was reduced to 5 mL by rotary
evaporator. The yellow oil was purified by column chromatography (SiO2) with eluent ethyl
acetate and hexane (v:v 1:1). The solvent was evaporated to produce a slightly yellow oil. The oil
was washed with 10 ml of 10 % HCl solution and then extracted with 30 ml of CH2Cl2. After
removing the solvent under vacuum, 0.74 g (92 %) of pale yellow oil was obtained. 1H NMR
(CDCl3, 500 MHz δ = 5.03 (dd, 1H), δ = 3.76 (s, 3H, OCH3), δ = 3.62 (s, 3H, OCH3), 2.67 (m,
1H, CH), 2.43 (m, 3H, CH & CH2CO). 13C NMR (500 MHz, CDCl3) δ (ppm): 172.4, 168.1,
161.5, 153.9, 143.2, 53.2, 52.2, 51.9, 30.6, 24.0. [α]D23 = -34.0 (c 1.00, acetone). HRMS (ESI)
calculated for [M + H]+ 376.1460, found 376.0104.
Glutamic methyl resorcinarene ester (GME). Methyl-resorcinarene (0.04040 g, 0.0742
mmol) and GPy (0.1240 g, 0.329 mmol) were put in a 10 mL two-neck dry flask connected to a
condenser and nitrogen gas inlet. 3 mL of dry DMF was added to the flask. Triethylamine (TEA)
(0.1140 g, 1.13 mmol) dissolved in 1 ml of dry DMF was added dropwise to the flask under an
atmosphere of N2. The stirring was continued for 8 hours at room temperature, followed by 12 h
at 60 °C. The solvent was removed under reduced pressure, and the solid was purified by column
chromatography (SiO2, ethyl acetate/hexane, 1:1) to yield as a yellow solid (0.0511 g, 38.8 %).
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Mp: 220-230 °C 1H NMR (500 MHz, CDCl3) δ (ppm): 7.39 (s, 2H), 7.27 (s, 2H), 7.18 (s, 2H),
6.90 (s, 2H), 5.017 (q, 4H), 3.98 (q, 4H), 3.64 (s, 12H), 3.51 (s, 12H), 2.40 (m, 8H), 2.18 (m,
8H), 1.69 (d, 12H). 13C NMR (500 MHz, d6-DMSO) δ (ppm): 172.9, 169.3, 163.6, 163.2, 155.3,
151.7, 150.7, 149.0, 142.3, 138.8, 135.2, 133.6, 125.8, 117.9, 53.2, 51.7, 51.0, 29.8, and 24.2.
[α]D23 = -24.8 (c 1.00, acetone). HRMS (ESI) calculated for [M + H2O + H]+ 1775.5350, found
1775.4465 , HRMS (MALDI) calculated for [M + Na]+ 1779.3935, found 1779.2547.
Glutamic methyl resorcinarene acid (GMA). Compound GME (0.1000 g, 0.0569
mmol) was dissolved in 3 mL tetrahydrofuran (THF) by stirring for 15 min at room temperature.
0.100 g of NaOH in 10 mL of H2O was added to the solution and the mixture was refluxed for 12
h until both layers turned to one clear layer. The solvent was neutralized to pH 7 and evaporated.
The solid was washed with CH2Cl2 and extracted with H2O. The H2O layer was collected and
acidified with 2 M HCl. The yellow precipitate was filtered. The filtrate was dried under vacuum
to dryness 0.0842 g (85.4 %). Mp: 240-250 °C. 1H NMR (500 MHz, d6-DMSO) δ (ppm): 12.451
(br, 8 H), 8.60 (m, br, 2H), 7.45 (m, br, 2H), 7.01 (m, br, 2H), 6.21 (m, br, 2H), 4.61 (s, br, 4H),
4.251 (s, br, 4H), 1.8 (m, br, 16H), 1.21 (s, br, 12H). 13C NMR (500 MHz, DMSO) δ (ppm):
173.4, 155.7, 148.5, 48.6, 42.0, 17.5. [α]D23 = + 9.57 (c 1.00, methanol). Anal. calcd. for GMA +
4H2O + 7HCl: C 46.28, H 3.74, N 7.74 %; found: C 46.28, H 3.42, N 8.52%. HRMS (ESI)
calculated for [M + 9H2O + H]+ 1806.3877, found 1806.3761.
Glutamic undecyl resorcinarene ester (GUE). Undecyl-resorcinarene (0.124 g, 0.113
mmol) and 5 (0.1860 g, 0.495 mmol) were put in a 10 mL two-neck dry flask connected to a
condenser and nitrogen gas inlet. 2.5 mL of dry dimethyl formamide (DMF) were added to the
flask. Triethylamine (TEA) (0.1140 g, 1.13 mmol) was dissolved in 1 ml of dry DMF and added
dropwise under an atmosphere of N2. The stirring was continued for 8 hours at room
56

temperature, followed by 12 hours at 60 °C. The solvent was removed under reduced pressure,
and the solid was purified by column chromatography (SiO2, ethyl acetate/hexane, 1:1) to yield
as a yellow solid (0.226 g, 82.8 %). Mp: 190-200 °C 1H NMR (500 MHz, d6-DMSO) δ (ppm):
7.59 (s, 4H), 7.29 (s, 4H), 4.98 (q, 4H), 4.79 (t, 4H), 3.26 (s, 24H), 2.59 (m, 4H), 2.44 (m, 4H),
2.15 (m, 16H), 1.28 (m, 72H), 0.926 (t, 12H), 13C NMR (500 MHz, d6-benzene) δ (ppm): 172.0,
168.2, 161.9, 154.2, 152.2, 141.6, 141.5, 134.2, 134.1, 123.7, 117.8, 51.0, 51.8, 52.2, 36.0, 32.0,
30.2, 29.9, 27.5, 24.3, 22.7, 14.0. [α]D23 = - 6.12 (c 1.00, acetone). HRMS (ESI) calculated for
[M + H2O + H]+ 2335.0428, found 2335.0873, HRMS (MALDI) calculated for [M + Na]+
2340.0215, found 2340.8124 .
Glutamic undecyl resorcinarene acid (GUA). Compound GUE (0.1000 g, 0.431 mmol)
was dissolved in 3.00 mL tetrahydrofuran (THF) by stirring for 15 min at room temperature.
0.100 g of NaOH in 10.0 mL of H2O was added to the solution and the mixture was refluxed for
12 h until both layers turned to one clear layer. The solvent was neutralized to pH 7 and
evaporated. The solid was washed with CH2Cl2 and extracted with H2O. The H2O layer was
collected and acidified with diluted HCl (2 M). The yellow precipitate was filtered. The filtrate
was dried under vacuum to dryness 0.0812 g (81.2 %). Mp: 220-230 °C, 1H NMR (500 MHz, d6DMSO) δ (ppm): 12.99 (br, 8H), 9.21 (m, br, 2H), 8.65 (m, br, 2H), 7.41 (m, br, 2H), 6.39 (m,
br, 1H), 6.05 (m, br, 1H), 4.45 (s, br, 4 H), 4.21 (s, br, 4 H), 2.19 (s, br, 4H), 2.10 (s, br, 4H),
2.81 (m, br, 16H), 1.28 (s, br, 72H), 0.926 (t, 12H). 13C NMR (500 MHz, d6-acetone) δ (ppm):
42.5, 33.0, 23.6, 14.7. [α]D23 = + 3.48 (c 1.00, methanol)Anal. calcd. for GUA + 6H2O + 4HCl: C
55.94, H 6.62, N 6.00%; found: C 55.81, H 6.14, N 6.73%. HRMS (ESI) calculated for [M +
9H2O + H]+ 2368.0055, found 2368.0144.
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2.3 Sample Preparation for Binding and Job Plot Studies
A 3.6 mM GMA stock solution was prepared by adding 0.0295 g of GMA to 5.00 mL of
DMSO at room temperature. Dilute solution of 0.0360 mM GMA was prepared in DMSO by
adding 30 µL of stock solution and diluting it to 3.00 mL. Amine guests, 8.20 mM were prepared
in DMSO. Guanidine compounds were purchased in HCl salts and therefore neutralized before
titration. They were neutralized in MeOH with KOH before the titration (1:1 molar ratio for
compounds guanidine (G), methylguanidine (MG), dimethylbiguanidine (DMG) and 1:2 for
Agmatine (AGM)). The methanol was to obtain neutral guests, which were dissolved in DMSO
for titration. To perform the binding constant titrations, 2.00 µL aliquots of each guest were
added to 3.00 mL of 0.0360 mM GMA solution and UV-vis spectra were taken after each
addition until the end point. The GMA solution was stirred between measurements. The binding
constant of guanidine compounds was calculated with a similar method using 0.0360 mM of
GMA and 6.60 mM of guests.
The binding constant was calculated using the following equation,
1/(I-I0) = 1/K(Ic-I0)[guest] +1/(Ic-I0)
where K is the binding constant, I0 is the absorbance intensity of the free host, I is the observed
absorbance intensity of the [guest-host] complex, and Ic is absorbance intensity at saturation. In
order to find K, 1/Ic-I0 was plotted against 1/[guest].19
The 3.6 mM GMA stock solution was prepared by adding 0.0295 g of GMA to 5.00 mL
of DMSO at room temperature. Dilute solution of 0.018 mM GMA was prepared in DMSO by
adding 100 µL of stock solution and diluting it to 20.00 mL. 2.7, 2.4, 2.1, 1.8, 1.5, 1.2, 0.9, 0.6
and 0.3 mL of the 0.018 mM GMA solution were taken and transferred to vials. The 1.2 mM
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guest 3 stock solution was prepared by adding 0.0121 g of guest 3 to 5.00 mL of DMSO at room
temperature. Dilute solution of 0.018 mM guest 3 was prepared in DMSO by adding 18 µL of
stock solution and reaching it to 20.00 mL. 0.3, 0.6, 0.9, 1.2, 1.5, 1.8, 2.1, 2.4 and 2.7 mL of the
0.018 mM guest 3 solution were taken and transferred to the each GMA solution. Each vial had
a total volume of 3 mL. After mixing them for a few seconds, UV-vis spectra were taken at room
temperature.

2.4 Sample Preparation for Mass Spectrometry and Electron Microscopy Imaging
Two different types of mass spectrometry were used, including electrospray ionization
(ESI) and matrix assisted laser desorption/ionization (MALDI). ESI mass spectra were obtained
by dissolving 5.00 mg of sample in 1.00 mL acetone and operating in positive mode. To obtain
mass spectra with MALDI, matrix preparation was required. The matrix was prepared by adding
10.00 mg of 3,5-dimethoxy-4-hydroxycinnamic acid (sinapinic acid) to 500 µL water:
acetonitrile (1% TFA). The obtained mixture was vortexed thoroughly for approximately 1
minute. The matrix solution was centrifuged for 30 seconds at 2,000 to 5,000 rpm. The
supernatant was collected and used as the matrix. Equal amounts of matrix and sample solution
(1.00 mg in 1.00 mL acetone) were mixed and 1.0 µL of the sample containing matrix mixture
was applied onto a stainless steel MALDI target.
Samples for SEM images were prepared by placing 0.00150 mM of samples in acetone
and water on silicon wafer chips with carbon-coated copper grids and sputtering 2-3 nm gold
nanoparticles on it. Samples for TEM were prepared by placing 0.0350 mM of samples in
acetone on the carbon grids.
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2.5 TGA
Water loss was studied through simple mass difference and Thermogravimetric analysis
(TGA). Mass loss of the sample was investigated by heating up to 200 °C. The mass loss
occurred at 100-140 ˚C with a corresponding DSC peak showing a chemical change at that
temperature. Gas chromatography was run during the TGA experiment and water vapor was the
only gas detected.

3. Results and Discussion
We have chosen to attach quinoxaline panels to resorcinarene molecules in preparing
large host molecules with deep cavities. The resorcinarenes were synthesized by condensation of
methyl or undecyl aldehyde with resorcinol. The synthesis of the panel quinoxaline was more
complex and required several steps to attach the amino acids to the upper rim. The first synthetic
steps entailed converting 1,2-phenylenediamine through four steps to dichloropyrazine anhydride
(Cl-Py-CO, Scheme 1). To form the panel with the amino acid ester (GPy), the anhydride was
reacted with glutamic amino acid ester. The anhydride provides a gateway into many chiral
panels simply by changing the amino acid.

60

O
H3CO
HOOC
a
H 2N

NH2

N

N
HO

OH
Q

b

N

N

Cl

Cl
Cl-Q

c

O

COOH

N

N

Cl

Cl

Cl-Py-COOH

O

d

O

N

N

Cl

Cl

OCH3

N

O
e

O

O

N

N

Cl

Cl

Cl-Py-CO

GPy

Scheme 1 Synthetic procedure for pyrazine molecules with glutamic ester. Conditions: (a)
oxalic acid, 2 M HCl, 2 h; (b) N, N-diethylanaline, phosphoryl chloride (POCl3), 120 °C 6 h;
(c) KMnO4, reflux 4 h, HCl; (d) oxalyl chloride (COCl)2, pyridine, dry THF, 0 °C 2 h, 50 °C
1 h; (e) L-glutamic methyl ester hydrochloride in acetic anhydride, 120 °C 4 h.

After the quinoxaline panel containing glutamic acid was added to the resorcinarene, the
new cavitand was formed (GME or GUE, Scheme 2). Methyl groups are incorporated into the
cavitand structure at the lower rim to facilitate greater solubility in polar solvents versus
substances with undecyl groups. The presence of undecyl chains at the lower rim provides
enough hydrophobicity to enhance solubility in non-polar solvents and adherence to hydrophobic
IC resins. The four pyrazine panels are bonded to the upper rim of the resorcinarene on the same
face of the molecule while each one has attached a glutamic acid residue. The ester derivatives
were hydrolyzed by sodium hydroxide and acidified with hydrochloric acid to form acid
derivatives of glutamic resorcinarenes (GMA or GUA, Scheme 2). The amino acids are bonded
to rings that contain heteroatoms. Therefore, these molecules are capable of forming both
hydrogen bonds and dipole-dipole interactions with other molecules. The presence of eight
carboxylic acid groups held in proximity to each other, are designed to facilitate binding to
amine compounds through hydrogen bonding and dipole–dipole interactions.
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Scheme 2 Synthetic steps to form the glutamic acid resorcinarene cavitands. Conditions: (f)
dry DMF, Et3N, rt 12 h; (g) THF, NaOH, 12 h, and HCl, H2O.

3.1 Characterization
3.1.1 Characterization by NMR
Resorcinarene cavitands have two spatial conformations: an expanded kite and a
contracted vase (Figure 1). The kite form has C2v symmetry and the vase form has C4v symmetry.
If the four panels are positioned vertically, the cavitand is the vase conformer and if the panels
are flat and extend outward, it is the kite conformer.2 One indication of the conformer is the
chemical shift of the lower rim methine proton. Others have shown that in less polar solvents
such as chloroform, benzene, and THF, the methine proton of the vase conformer appears at δ ≈
5.5 ppm or further downfield, while the methine in the kite conformer appears at δ ≈ 3.7 ppm.36
Along with solvent, temperature and pH can influence conformer concentration.
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Figure 1 Conformational interconversion of kite and vase. 1H NMR of methine proton in vase,
kite with slow kite1−kite2 interconversion, and kite with fast kite1−kite2 interconversion has
indicated. Four aromatic signals of kite with slow kite1−kite2 interconversion, and two
aromatic signals for kite with fast kite1−kite2 interconversion has shown.
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The chemical shift of the methine protons (Ha in Scheme 2) in GME in CDCl3, d6acetone and d6-DMSO appeared at 3.87, 4.14 and 4.01 ppm, respectively. These values are
intermediate in chemical shift between reported vase and kite structures, but closer to the kite
conformation. The methine protons of GUE in CDCl3, d6-acetone and d6-DMSO appeared at
4.12, 3.92 and 3.77 ppm, respectively, and are also closer to the kite conformation. However, in
d6-benzene the methine was downfield and appeared at 4.79 ppm, which indicates the structure is
closer to the vase conformation. In accordance with a recent report on vase-kite conformational
interconversion by Diederich and Pochorovski,37 the repulsive interactions between the
protonated nitrogens and carbonyl groups on the resorcinarene cavitand promote the kite
conformer and hinder the formation of the vase conformer.
The presence of two signals for the aromatic protons (Hb and Hc) of GME in CDCl3 and
d6-acetone, shows the slow interconversion between the two kite conformations (Figure 1).
However, GME showed four aromatic signals in d6-DMSO at room temperature; at 6.91, 7.19,
7.28 and 7.40 ppm, which indicates some distortion and lack of perfect C2V symmetry of the kite
conformation.
According to previous studies, the vase conformation is favored at higher temperatures.36
GME didn’t show any specific changes of methine signals at higher temperature up to 80 ºC in
d6-acetone, d6-DMSO, and CDCl3, which indicates the stability of the kite conformer (Figure 2).
Although, as temperature was increased to 80 °C in d6-DMSO, the four signals of aromatic
protons started to coalesce into one sharp peak at 7.23 ppm. This trend indicates the fast
interconversion between kite1-kite2 conformations at higher temperatures with preference for
C2v symmetry structure.
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GME

GUE

Figure 2 1H NMR spectra of aromatic signals GME (left) and GUE (right) in d6-DMSO at
different temperatures.

Although GUE appears to be in the vase form in benzene, the presence of two aromatic
peaks at 7.24 and 7.60 ppm shows that GUE is not in a perfect vase conformation. Benzene is
better at stabilizing the vase conformation than the other solvents. Two important factors
contribute to destabilize the vase conformation of such cavitands: cavity solvation and solvent
hydrogen-bonding acidity.38 Benzene can stabilize the vase conformation because benzene is
nearly complementary to the cavity size and consequently can fit into the inner cavity of the vase
structure. The lack of hydrogen-bonding interactions between benzene and nitrogens of the
quinoxaline arms promotes the vase conformation.37
As mentioned earlier, based on the chemical shift of the methine protons, GUE prefers
the kite structure. GUE showed two signals for aromatic peaks in d6-acetone, CDCl3, and d6benzene which indicates slow interconversion between kite1-kite2 conformations. Two relatively
broad aromatic signals at 7.24 and 6.78 ppm were observed for GUE in d6-DMSO. Based on
this observation and signal integration, GUE prefers one conformer of kite with very slow
interconversion to the other conformer. Further investigation was performed with 1H NMR
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studies at various temperature (VT-NMR) and is shown in Figure 2. As temperature was
increased to 80 °C, two aromatic signals appeared at 7.24 and 7.08 ppm. They were resolved
equally and sharpened compared to 25 °C. Thus, GUE at elevated temperatures in DMSO
undergoes slow interconversion between kite1-kite2 conformations.
According to published studies, the kite structure is the predominant conformation at
lower temperatures.38 At low temperature, solvation energies stabilize the kite structure with its
solvent-exposed surface. The methine signals appeared at 4.01 (GME) and 4.10 (GUE) ppm in
CDCl3 at 25 °C. As the temperature was lowered to -5 °C in CDCl3, the 1H NMR signals of
GME and GUE started to broaden and lose splitting. The aromatic signals broadened and
underwent coalescence as the temperature reached -5 °C (Figure 3). Apparently, at lower
temperatures, the chemical exchange is slower than the NMR timescale, and therefore signals are
broader.

GME

GUE

Figure 3 1H NMR spectra of aromatic signals GME (left) and GUE (right) in d6-DMSO at
different temperatures.
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GMA and GUA showed the kite structures in d4-methanol, d6-acetone and d6-DMSO.
VT-NMR experiments on the GMA showed that the chemical shift of the methine proton didn’t
change in acetone from 25 to -5 °C. Likewise, the methine peak did not show any obvious
movement from 25 to 80 °C in d6-DMSO. These observations indicate that the kite structure is
stable for GMA. The 1H NMR signals of GMA and GUA were broad. These cavitands have
polar and non-polar ends, which facilitate aggregation. The presence of eight carboxylic acids for
each molecule can form inter- and intra-molecular hydrogen bonds in the aggregation which lock
the movement of the molecule. This results in protons not being able to freely rotate, and thus
chemically equivalent protons are in different environments, leading to broad NMR signals.

3.1.2 Characterization by MS
Mass spectrometry was used for further characterization of the resorcinarenes. By
MALDI the GME mass was observed at 1779.25 m/z which is consistent with the calculated
mass of GME + Na+ of 1779.39 amu. The molecular ion peak was also observed at 1757.52 m/z
with a smaller intensity. The GME mass was analyzed with ESI-MS as well. The GME mass
was obtained with a +1 molecular ion peak at 1757.52 m/z. The mass difference between the
calculated value and the experimental value (1775.53) was an ammonium ion.
The mass spectrum of GUE was obtained with similar methods. The molecular weight
of the compound is 2317.03 g/mol. The GUE mass was observed at 2340.81 m/z, which is
consistent with the mass of GUE + Na+. The molecular ion peak was also observed at 2318.84
m/z, but with less intensity. The GUE mass was analyzed with ESI-MS as well and its mass was
observed at 2335.08 amu. The mass difference between the calculate value (2317.03) and this
experimental value (2335.08) was NH4+.
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The acid derivatives of resorcinarene cavitands (GMA and GUA) were also analyzed
with MALDI and ESI techniques. The molecular ion peaks were not able to be observed using
MALDI. Using ESI, the molecular ion peak for GMA was found to be 1806.37 amu. The mass
difference between this value and the calculated value for the parent ion was 162.09 amu. A
mass of 162 equals eight water molecules and one ammonium, which waters and ammonium
could have been picked up from the eluent. With eight carboxylic acids, GMA would have one
water associated with each carboxylic acid. The GUA was analyzed by the similar method and a
+1 molecular ion peak at 2368.01 m/z was observed. The mass difference between this mass and
the calculated value is 163.10 amu. Apparently, GUA also flies with 8 water molecules, as well
as a hydronium. Water was also observed in 1H NMR spectra of GMA and GUA, but varied
from 3-5 molecules per cavitand. Previously in our group, the presence of 8 water molecules
associated with a similar resorcinarene was observed by SORI-CID FTICR MS technique.15
To further characterize the acid derivatives, they were analyzed with thermogravimetric
analysis (TGA). An oven dried sample of GMA was used to measure the amount of water in the
sample. As temperature was increased to 140° C, GMA lost water which was calculated to be 5.3
H2O per GMA molecule on average. Further increase in temperature didn’t change the amount
of water given off, but caused sample burning.

3.2 Binding ability of GMA to amine and guanine compounds
3.2.1 Binding ability to amine compounds
The GMA molecule, with its carboxylic acids, was designed to bind amines through
hydrogen bonding. A series of amine guests that varied in structure were chosen to test the
factors important to binding (Figure 4). We first investigated primary, secondary and tertiary
benzyl amines and then compared them to aliphatic and naphthyl amines. We then investigated
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the affect of chirality on binding. The host and guest molecules were soluble in DMSO and so
this was chosen as solvent for the binding studies. We also examined binding in water, but
observed no significant changes in the UV-vis spectra. We attribute the weak binding in water to
the highly solvated ammonium species that the guests form in water.
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Figure 4 Structure of the guests and PGA.
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As a solution of amine guest was incrementally added to a solution of GMA, the GMA
peak at 280 nm decreased and the peak at 340 nm increased (Figure 5). Compound 3 is shown as
an example, but a similar increase and decrease in the UV-vis spectra was observed for each of
the amine guests in Figure 4. Plotting the absorbance at 340 nm versus [guest]/[host], showed an
increase in absorbance to around four equivalents of guest (Figure 6), after which the absorbance
did not change. This indicates that four guest molecules are associating with one GMA host.

Figure 5 UV-vis absorption of GMA with amine guest (3). Conditions: 3 (0.0082 M) was
added in 2 µL increments to GMA (0.0360 mM) at 22 °C in DMSO.
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Figure 6 UV-vis absorbance change with added 3 (G) to GMA [H]. Conditions: 3 (0.0082
M) was added in 2 µL increments to GMA (0.0360 mM) at 22 °C in DMSO.

To determine the stoichiometry of the binding, job plot analysis was performed.39 The
mole fraction of guest was plotted against absorbance (Figure 7). The maximum point of the plot
occurs at X = 0.8 and correlates to a 4:1 guest to host binding. (Figure 7 a) To confirm the
stoichiometry of the binding, absorbance for another Job plot was obtained using one fourth the
concentration of GMA corresponding to binding to just one of the resorcinarene arm per guest
(Figure 7 b). The maximum at XHG = 0.5 for this plot and shows 1:1 guest to arm of host binding.
These job plots indicate that four guest molecules bind to each host or one guest molecule binds
to each arm.
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Figure 7 Job plots of guest 3 with GMA. [H] = [G] (a, left) and [Panel] = [G] (b, right).
Conditions: [H] = [G] = 0.018 mM, [Panel] = [G] = 0.018 mM.

With the knowledge of the binding stoichiometry, host-guest titrations were performed so
that binding constants could be calculated (Table 1). The binding constants were calculated using
one guest per one arm of host so 1:1 binding isotherms could be used. The percent error for three
binding constant measurements for one guest was 12 %. Different guest substituent factors such
as size, type, number, and position were investigated.

Table 1 Binding constants of amines to GMA in DMSO. [H]: 0.0360 mM, [G]: 8.20 mM.
Guest
K (M-1)
Guest K (M-1)
40,000
55,000
1
2
96,000
98,000
3
4
126,000
89,000
5
6
73,000
70,000
7
8
13,000
12,000
9
10
40,000
36,000
11
12
85,000
73,000
13
14
15.HCl NCa
16.HCl -----a
3.HCl
NCa
74000
17
-----a
-----a
18
19
a: Not calculated, too small to measure, < 1000.
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3.2.1.1 The effect of substituent group
Benzylamine (1) and 4-methylbenzylamine (2) show binding to GMA and gave binding
constants of 40,000 and 55,000 M-1, respectively (Table 1). Although these binding constants are
fairly similar to each other, they are very different from benzyl alcohol and benzonitrile, which
showed no appreciable binding to GMA. We attribute the strong binding of organic amines to
GMA to the formation of cation-anion complexes. The carboxylic acids of GMA will protonate
the amine of the guest and form a carboxylate-ammonium ion pair (R-NH2 + R’-COOH→ RNH3+ + R’-COO-). These ions form stronger attractions to each other than they do to the polar
DMSO. This anion-cation interaction is critical as shown by the weak binding of the alcohol and
nitrile guests.
The effect of electron donating group on the basicity of the amine functional group was
studied. Guests 3 and 4 with binding constant of 96,000 and 98,000 M-1 respectively, carry an
electron donating –CH3 group on the α-carbon which increases the electron donating ability of
the neighboring -NH3+ group by an inductive effect, thereby enhancing the binding between
amine and GMA in comparison to 1 and 2. Guest 5, with a binding constant of 126,000 M-1,
showed a larger binding constant than 3 and 4, which can be explained by the same hypothesis.
The presence of methyl groups on the geminal carbon of 5 enriches the electron density on the
amine group more than the methyl group on 4.
The basicity of amine functional groups may be modified by steric hindrance. The
binding constant of 7 and 8 are 73,000 and 70,000 M-1 respectively, significantly less than those
for primary and secondary amines 3 and 5. The presence of two methyl sterically inhibits the
interactions between amine and acid groups. The effect of hindrance also was observed for 9 and
10, which have naphthyl groups in their structures and gave binding constants of 13,000 and
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12,000 M-1-, respectively. Noticeably, their binding strength was smaller than those of the amines
with one phenyl ring, such as 3 and 4. Also, in the case of 9 and 10, the presence of naphthyl
groups increases the hydrophobicity of the compound resulting in more solvation by DMSO and
less binding to GMA.
Whether the amine groups in the guest are bonded to aliphatic or aromatic groups plays a
role in binding strength to the host molecule. The cyclic aliphatic guests 11 and 12 showed
weaker binding (40,000 and 36,000 M-1 respectively) than the benzylic amines 3 and 4. The
aliphatic diamines 13 and 14, with two amines per molecule, gave binding constant equal to
85,000 and 73,000 M-1 respectively, and showed stronger interaction with GMA than aliphatic
amines 11 and 12. The number of nitrogens enhances the binding. Secondary aliphatic amines 13
and 14 with binding constant of 73,000 and 70,000 M-1, showed smaller binding strength than
secondary aromatic amines 7 and 8. This result also can be explained by lack of conjugate
system in their structures.
Protonated amines proved not to bind to GMA. The amine guests 15 and 16, which have
their amines already protonated, showed no binding to GMA. To confirm this result, 3 was
protonated with hydrochloric acid before the titration. Unlike 3, the protonated species of 3
exhibited no measurable binding to GMA.
Phthalyl glutamic acid (PGA, Figure 4), an analogs of a cavitand side panel, here also
titrated with primary and secondary amines 3 and 4, and 5 and 6. Their binding constants were
found to be 5800 and 3400, and 10400 and 6400 M-1 respectively. Compared to GMA which
contains eight carboxylic acid groups on the upper rim, the monoacid PGA showed much
weaker interactions with amines. We propose the carboxylic acids on GMA are binding in a
cooperative manner resulting in a larger binding constant.
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3.2.1.2 Chiral recognition
Previously in our group, alanine-containing cavitands (AUA and AMA) were synthesized
and studied for chiral recognition with chiral amines by 1H NMR titrations. Since the glutamic
acid-containing cavitands GMA and GUA carry chiral groups on the upper rim, experiments
were conducted to examine the ability of these hosts to discriminate between enantiomeric guest
molecules. The UV-vis titration studies showed that secondary amines 5 and 6 (enantiomeric
pair) with binding constant of 126,000 and 89,000 M-1 respectively, showed distinct chiral
discrimination. S enantiomers showed larger binding constants for most of the chiral amines
(Table 1).
3.2.2 Binding ability to guanidine compounds
Guanidine compounds are water contaminants of emerging concern and their detection
and quantification is essential to their removal from water. Noting the ability of GMA to bind
amines, we tested its ability to bind guanidines. The binding of GMA to guanidines would
potentially lead to its use as an ion exchange material in ion chromatography stationary phases.
Indeed, the undecyl derivative, GUA, was successfully used as an ion exchange material for ion
chromatography (IC) columns.40
A family of guanidine known pharmaceuticals compounds, were chosen that had
different substituents (Figure 8). As a solution of guanidine guest was incrementally added to a
solution of GMA, the GMA peak at 280 nm decreased and the peak at 340 nm increased as was
observed for the amine guests. Plotting the absorbance at 340 nm versus [guest]/[host], showed
an increase in absorbance to around four equivalents of guest 23, after which the absorbance did
not change (Figure 9). As with the other amines, four guests are associating strongly with GMA,
corresponding to the 4 arm.
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Figure 8 Guanidine compounds.

Figure 9 UV-vis absorbance change with added 23 to GMA. Adding guest 23 to the 0.0360
mM of GMA and monitoring the peak shift at 340 nm. The absorbance at 340 nm is plotted
vs the [guest 23]/[host] concentration.

Table 2 Binding constants of GMA and guanidine molecules. [GMA] = 0.0360 mM, [G] =
6.6 mM.
Guest
20
21
22
23
24

K (M-1)
153,000
128,000
102,000
43,000
4300
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Guanidine (20) showed the strongest binding, K = 153,000 M-1 while the guanidine
derivatives showed smaller binding constants (Table 2). Guanidine derivatives can be protonated
and form cations and di-cations in solution. The high polarity and charge density of 20 leads to
strong interactions with carboxylic acids of GMA. The presence of alkyl groups in their structure
increases the hydrophobic properties of the molecule and, interestingly, guest 24 (the most
hydrophobic molecule in the list) showed the smallest binding constant of 4300 M-1. The highly
solvated guests interact more weakly than the non-solvated ones. We also examined binding in
water, but observed no significant changes in the UV-vis spectra. We attribute the weak binding
in water to the highly solvated guanidine species that the guests form in water.

3.3 Particle size Analysis
As mentioned, the presence of polar and non-polar ends in resorcinarene molecules can
result in the formation of aggregates. DLS was used to confirm the presence of agglomerated
glutamic acid resorcinarene cavitands in different solvents. For the esters, 0.854 mM GME and
0.647 mM GUE were analyzed in acetone, chloroform and DMSO and the results are shown in
Figure 10 a and b. The observed average diameter of GME aggregates was ~200 nm. As the
peak broadness shows, there is larger particle size distribution in DMSO than acetone and
chloroform. The average diameter of GUE was ~400 nm and, again, the greatest size distribution
was in DMSO.
Acid derivatives GMA and GUA, showed one or two major particle distributions, one at
a small diameter particle size and another at a larger diameter (Figure 10, c and d). Average
particle diameter for GMA showed larger size distribution in water (~100 nm) and DMSO (~200
nm), while a sharper peak appeared in acetone and methanol (~140 nm). The GUA average
diameter was observed at ~ 300 nm in DMSO and ~ 400 nm in acetone and MeOH.
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Figure 10 Particle size comparisons of GME (a) and GUE (b) in acetone, CHCl3 and
DMSO, GMA (c) and GUA (d) in DMSO, MeOH, acetone and H2O. Conditions: GME
(0.854 mM), GUE (0.647 mM), GMA (0.608 mM) and GUA (0.453 mM), room temperature
measurements.

Several factors affect agglomeration formation including concentration, pH, and
temperature.41–43 According to previous studies, dilution may assist in reducing agglomeration.44
The size distribution range for GMA (1.940 – 0.0061 mM) in DMSO showed the presence of a
large numbers of smaller particles (≤ 5 nm) at lower concentrations. (Figure 11). This analysis
represents the number of particles versus their sizes. The majority of particles at 0.015 mM have
sizes of ≤10 nm. However, DLS analysis indicated that larger particles (~ 100 nm) with less
numbers are also present at 0.015 mM GMA solution.
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The effect of pH on the aggregation behavior of GUA was investigated by DLS
measurements. Results were obtained for range of pH (10.1 – 3.80), as shown in Figure 12. Both
acidic and basic environments helped to reduce the size of particles. More importantly, larger
particles were transformed to micellar structures at acidic pH (3.80). A significant decrease in the
agglomeration diameter from 200 nm at pH 7 to 10 nm at pH 3 were obtained. The decrease in
pH results in protonation of amine groups which can enhance the electrophilic repulsion among
the particles. The effect of acidic pH on GUA provides potential for applications in selective
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Figure 11 Particle size distribution of GMA in DMSO at different concentrations.
Conditions: Room temperature measurements.
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Figure 12 Particle size distribution of GUA at different pHs Condition: GUA in H2O (0.253
mM), room temperature measurements.\

The effect of temperature on particle size was also studied. Higher temperatures tended to
reduce the particle size distribution and sharpen the signals (Figure 13, a). As temperature
increased to 80 °C, 0.854 mM GUA showed significantly sharper peaks. The VT-NMR of GUA
also showed sharpened proton signals at higher temperatures. In the other hand, as the
temperature was lowered in acetone, peak sharpness decreases and particle size distribution
noticeably increased. This can explain the VT-NMR studies of GME at lower temperatures
where peak broadness and loss of splitting occurred (Figure 13, b).
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Figure 13 Particle size distribution of GUA in DMSO and GME in acetone at different
temperatures. Condition: GUA (0.854 mM) and GME in acetone (0.253 mM).

3.4 Electron Microscopic Analysis
The aggregation behavior of ester and acid derivatives of glutamic acid resorcinarene
cavitand was investigated by TEM and SEM. The GME and GUE showed spherical
agglomerations with average dimension of 200 - 500 nm, respectively (Figure 14, a and b). The
observed dimensions were consistent with the DLS measurements. Furthermore, GME and GUE
showed a narrow distribution of spherical agglomeration by SEM (Figure 14, c and d).
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a

c

b

d

Figure 14 TEM and SEM images of GME (a and c) and GUE (b and d). Conditions: 0.0066
mM ester derivatives were prepared in acetone for TEM and SEM analysis. SEM samples
were sputtered with gold before imaging.

SEM images of the GMA and GUA were obtained and showed spheres with wider size
distributions than ester derivatives (Figure 15, a and b). Additionally, floccule structures were
observed in a water solution of GUA after 1 week. Previous studies by Huang et al. showed that
these type of structures became consistently larger the incubation time increased.45 The
morphology of these aggregates was examined by SEM are shown in Figure 15, c and d.
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b

a

d

c

Figure 15 TEM images of GMA (a), GUA (b), and GUA (c and d). Conditions: 0.0066 mM
of GMA (a) and GUA (b) were prepared in acetone. 0.0066 mM of GUA incubated for 1
week in water.

As mentioned, increasing temperature leads to smaller particle size with significantly
narrower size distribution. SEM images of GME (a) and GUE (b) were obtained from 0.0066
mM acetone solution on the surface of a hot silicon wafer (Figure 16, a and b). The obtained
SEM images show the formation of smaller sized particles than the particles at room temperature
(Figure 14) for the ester derivatives.
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b

a

Figure 16 SEM images of GME (left) and GUE (right) cavitands, dissolved in acetone and
dried on a silicon grid at 60 ˚C.

Conclusion
Deep chiral cavitands GMA and GUA were synthesized and characterized by different
techniques. They have a tetramer structure. Ester and acid derivatives were fully characterized
with NMR, mass spectroscopy, DLS, SEM, and TEM techniques. A series of amine guests with
different substituent groups were used to analyze the binding strength and chiral recognition of
GMA in DMSO. A comparison of binding constants between GMA and PGA showed the
importance of tetramer structure in enhancing the binding strength between amines and host
molecules. The greatest chiral discrimination was observed for secondary amines. DLS analysis
showed the presence of agglomeration for ester and acid derivatives. The stimuli for reducing
agglomerations were found to be concentration, pH, and temperature.
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Chapter 3 Separation of Uremic Toxins from Urine with Resorcinarene-based
Ion Chromatography Columns
Abstract 1
People with chronic kidney disease suffer from uremic toxins which accumulate in their
bodies. Detection and quantification of uremic toxins help diagnose kidney problems and start
patient care. The aim of this research was to seek a new method to assist this diagnosis by trace
level detection and separation of guanidine containing uremic toxins in water and urine. To
detect and quantify the uremic toxins, new stationary phases for ion chromatography (IC)
columns based on glutamic acid functionalized resorcinarenes bound to divinylbenzene
macroporous resin were prepared. The new column packing material afforded separation of the
five compounds: guanidinoacetic acid, guanidine, methylguanidine, creatinine, and
guanidinobenzoic acid in 30 minutes. Peak resolutions ranged from 7.6 to 1.3. Gradient elutions
at ambient temperature with methanesulfonic acid (MSA) solution as eluent resulted in detection
levels in water from 10 to 47 ppb and in synthetic urine from 28 to 180 ppb. Limits of
quantification for the analytes using pulsed amperometric detection were 30 to 160 ppb in water
and 93 to 590 ppb in urine. Trace levels of creatinine (1 ppt) were detected in the urine of a
healthy individual using the columns.

Keywords: uremic toxins; resorcinarene; separations; ion chromatography

This research has been published.
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1

89

1. Introduction
Chronic kidney disease (CKD) affects more than twenty million Americans. When the
kidneys do not function correctly, molecules are not excreted from the body, resulting in adverse
effects such as impaired cognitive functions and epileptic seizures [1,2]. These harmful
compounds are called uremic toxins and range from small water-soluble molecules to large
proteins. Detection of abnormal concentrations of uremic toxins in blood or urine indicates a
person has CKD and needs treatment. New methods to quantify uremic toxins are being
developed and one is the subject of this research [3-7].
One subgroup of uremic toxins contains the guanidine unit and includes: guanidine (G),
methylguanidine (MG), guanidinoacetic acid (GAA), guanidinobenzoic acid (GBA), and
creatinine (CRN) (Figure 1). It has been shown that the levels of these guanidine molecules
increase in biological fluids and tissues in patients with CKD and that abnormal levels of these
compounds are toxic [8-10]. In another study, it was found that the levels of some guanidine
compounds increased greatly in serum and cerebrospinal fluid of uremic patients, while the
levels of other compounds in this group were not changed or even decreased [11-13].
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Figure 1 Uremic toxins guanidine (G), guanidine acetic acid (GAA), methylguanidine
(MG), creatinine (CRN) and guanidine benzoic acid (GBA).

There is significant clinical importance for sensitive and selective methods to determine
trace amounts of these compounds in biofluids. Chromatography is a common analysis method
and has advantage over enzymatic and spectrochemical methods in that it has the ability to
separate and detect multiple components while eliminating interfering species [11.12]. Among
the different chromatography methods, reversed-phase high performance liquid chromatography
(HPLC) has been applied to quantify uremic toxins [14]. Several detection methods have been
used with HPLC. Lack of strong chromophoric groups for UV-vis detection in some of the
uremic toxins led to the use of derivatizing reagents with reverse-phase HPLC [9,10,15,16].
Also, mass spectrometry has been coupled to HPLC to detect uremic toxins [17-20].
Although guanidino uremic toxins are protonated in aqueous solution and are thus ionic,
there are only a few examples of ion chromatography (IC) applied to their separation [16,21-23].
As previously mentioned [14], IC columns were used in conjunction with HPLC to preconcentrate or separate polar compounds [24,25]. Also, three ion exchange chromatography
methods, a strong cation-exchanger (RSO3-), weak cation-exchanger (RCOO-) and a reversed91

phase column, were compared for the determination of creatinine in serum [26]. The weak cation
exchange method was preferred due to less interference of matrix, higher success in
determination of the favored analyte, and the simplicity of the method.
IC has shown promise in the quantification of many pharmaceuticals such as antibiotics,
drugs, drug impurities and excipients [27]. Two recent studies separated uremic toxins from
biological fluids using IC. One study analyzed creatinine in mouse and rat serum by an ion
exchange chromatography system [8]. Another study showed the determination of guanidine in a
high salt and protein matrix and applied the cation exchange column Dionex CS14 (4 × 250 mm)
and a guard column (4 × 50 mm) [16]. As with HPLC, several IC systems rely on pre- or postcolumn derivatization for detection of guanidino compounds and uremic toxins [11, 28, 29].
To alleviate the need of derivatization, we considered electrochemical detection (ED) to
be a good option. The combination of ED and IC for the detection of guanidine compounds has
not been explored; however ED has been successfully employed to detect some pharmaceuticals
[27]. For example, one study reported using a Ni2O3 electrode with anion-exchange
chromatography to determine the effect of eluent concentration on uremic dialysate and serum
samples [30].
In this paper we demonstrate that a new IC packing material effectively separates uremic
toxins in aqueous media and urine by a straightforward method. The new column packing
material contains resorcinarene-based molecules functionalized with glutamic acids (GUA).
Resorcinarenes have proven to be excellent separation materials for IC [31-33]. The separation
and quantification in this work was accomplished with a cation-exchange stationary phase and
the direct detection with ED; as a result, pre- or post-column derivatization reagents were not
needed. The robustness of the column at room and elevated temperatures were examined and
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found to be excellent. This direct detection of nanomolar amounts of uremic toxins in urine with
easy sample preparation provides a simple method for determination of these toxins.

2. Materials and methods
2.1. Reagents
Analytical grade reagents including 50% NaOH solution, methanesulfonic acid (MSA),
and guanidine compounds were obtained from commercial suppliers. Milli-Q water, 18
Megohm/cm resistivity, was utilized in the preparation of all eluents and standards. A solution of
1 M sodium hydroxide was used as the post column additive for pulsed amperometric detection.
The glutamic acid resorcinarene was synthesized in a manner similar to previous compounds
[34]. Thermo Scientific (Sunnyvale, CA) provided the 4.6 μm particle size styrenedivinylbenzene polymeric macroporous resin.

2.2. GUA column preparation
To prepare the column material, a slurry was made of 0.050 g of the glutamic acid
resorcinarene, 1.5 g of polystyrene resin and 25 mL of methanol. After mixing thoroughly the
slurry was dried at room temperature. Then the resin material was ground with a mortar and
pestle for 4 hours while 30 mL of deionized water was added slowly. After this, the resin was
packed into a 3 x 150 mm black PEEK column at 60 °C and 4000 psi for 15 minutes using a
Haskel high pressure pump.
The GUA column was packed with 55% cross-linked divinylbenzene macroporous resin
with the average diameter of 4.6 µm. The resin surface area was 350 m2/g and the applied amount
for each column was 1.5 g. With the length of GUA at 3 nm, the resin could accommodate 6.0 x
10-5 mol, (0.117 g) of GUA lying down lengthwise on the resin. Adding 0.050 g of GUA and
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realizing all of it will not by lying flat on the surface, means that less than half of the resin is
occupied by GUA.

2.3. Analyte preparation for separations and calibration curves
Dilute solutions (50 and 100 ppm) of each analyte were prepared in deionized water from
300 ppm stock solutions and stored in plastic bottles in the refrigerator at 4 °C. The synthetic
urine was prepared according to the method published [35]. The urine was centrifuged at 4000
rpm for 5 min and filtered through a 0.25 µm mesh Thermo Scientific Nalgene syringe filter,
which is a surfactant-free cellulose acetate filter. The filtered solution was kept in a plastic bottle
in the refrigerator at 4 °C. The real urine sample from a healthy individual was filtered through
cellulose filter paper and centrifuged at 1000 rpm for 10 min. It was then passed through a 2 μm
Nalgene syringe filter, a 3k Millipore Amicon ultra centrifugal filter, and Strata C18-E (55 μm,
70A). Before analysis, 1 mL of synthetic urine was diluted to 5 mL and 0.5 mL of real urine was
diluted to 5 mL with Milli-Q water.
For the calibration curves, each analyte was analyzed separately three times and the
solution concentrations for integrated pulsed amperometric detection (IPAD) ranged from 1 - 10
ppm in water and 2 - 60 ppm in the synthetic urine. To calculate the limit of detection (LOD),
the equation LOD = 3.3(SD/S) was used where SD is the standard deviation and S is the slope of
the line of the calibration equation. Limit of quantification (LOQ) was obtained by the equation
LOQ = 10(SD/S). To calculate the linearity of the procedure, 5 different concentrations of
analytes were added to the urine solution.
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2.4 Column capacity
Dynamic binding capacity was measured by breakthrough curves using guanidinebenzoic
acid (GBA) as electroactive sample. The packed column was flushed with a 20 mM NaCl
solution for 30 min and water for 30 min at 0.3 mL/min. Then, 1 mM GBA was passed through
the column at 0.3 mL/min. The dynamic binding capacity was calculated using the equation: Q =
CF(tb-tv), where Q is the dynamic binding capacity (mM/column), C is the concentration of
GBA, F is the flow rate (mL/min), tb is the breakthrough time (min), and tv is the void time (min)
[36]. Column porosity was calculated by dividing the column void volume by the total empty
column volume. The void volume, 0.66 mL, was found by multiplying the void time (2.2 min)
by the flow rate, (0.30 mL/min). The total volume for the column (3 x 150 mm) was 1.06 cm3.

2.5 SEM sample preparation
Resin for SEM images was prepared by placing resin on carbon-coated copper grids and
sputtering 2-3 nm gold nanoparticles on it.

2.6 Pulse amperometric detector
The electrochemical waveform was +0.13V from 0.00 to 0.05 s, +0.33V from 0.05 s to
0.21 s, +0.55V from 0.22 s to 0.46 s, +0.33V from 0.47 s to 0.56 s, −1.67V from 0.57 s to 0.58 s,
+0.93V at 0.59 s, and +0.13V at 0.60 s. The pH reference electrode mode with current integrated
was set up between 0.21 and 0.56 s for detection. This waveform is an AAA-Direct waveform,
which is composed of a 4-potential program and uses reductive cleaning rather than oxidative
cleaning [37]. This pattern preserves the gold working electrode surface. In this study, an
integrated pulsed amperometric detection (IPAD) waveform was used to determine uremic
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toxins which is an enhanced 4-potential program. The basic advantage of the IPAD waveform is
the detection of analytes using one more potential than the PAD waveform.

2.7. Instrumentation
A Dionex ICS-3000 chromatography system (Thermo Scientific, Sunnyvale, CA, USA)
with an AS40 autosampler and integrated pulsed amperometric detector (IPAD) were used. A
gold working electrode (conventional) and Ag/AgCl reference electrode were equipped on the
IPAD. The injection volume for the IPAD was 5 μL. The Dionex Chromeleon workstation ran
the collection and subsequent data analysis. Basic pH conditions were needed at the surface of
the gold electrode and were provided by a post column reactor (pneumatic pump) containing 1 M
NaOH by means of a mixing-T at a flow rate of 0.5 mL/min. The pH at the reference electrode
was 12.5-13.0. The delivery rate of sodium hydroxide solution was adjusted to keep the pH
constant at different concentrations of acidic eluent. Dionex IonPac CG17 was used a guard
column for the real urine samples. Columns were operated at room temperature. SEM images
were taken on a FEI Helios Nano lab 600.

3. Results and discussion
3.1. Separators
Macrocyclic compounds such as crown ethers, cryptands, and cyclodexterins have for
years been incorporated into the stationary phases of chromatography systems to improve the
separation selectivity and efficiency of the columns [38-40]. Calixarenes and resorcinarenes,
another family of macrocycles, having surfaces easily functionalized with polar, cationic and
anionic groups, have achieved excellent separations of some species [41-45]. As a way to create
new stationary phases, our group has designed IC columns based on resorcinarenes that
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selectively separate cations and anions [46,47]. In the present research, the resorcinarenes were
synthesized by adding glutamic acid groups to quinoxalines, which quinoxalines were in turn
bonded to a resorcinarene scaffold (Figure 2). These resorcinarenes contain eight carboxylic
acid groups clustered on one face of the molecule. Depending on pH, the acid groups will be
neutral or anionic and provide cation exchange sites. Furthermore, the phenyl groups at the
midsection of the resorcinarene can interact through hydrophobic interactions with nonpolar
groups on the analyte. The long alkyl chains on the lower rim of the resorcinarene are designed
to act as adhering groups to the polystyrene packing material, a method that has repeatedly been
shown to provide long-term column stability [31,34].

Figure 2 Glutamic acid resorcinarene with undecyl groups (GUA).
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3.2 Separation of guanidine compounds in water and urine on the GUA column
3.2.1. Isocratic elution in water
The effect of different concentrations of MSA on the retention times of standards was
examined and the results are shown in Figure 3. Rinsing the column with the concentration of
MSA used as eluent for 10 min before each injecting allowed the column to equilibrate and was
important to obtain a reproducible analyte separation. Concentrations of 1, 2, 3, and 4 mM MSA
resulted in the elution of all of the compounds, except the GBA. With 1 mM MSA, retention
times were 6.31 (GAA), 7.21 (G), 8.81 (MG), 9.66 (CRN) min. Increasing the eluent to 4 mM
resulted in retention time decreases to 6.01 (GAA), 6.50 (G), 6.98 (MG), 8.13 (CRN);
concurrently, resolution was reduced. Increasing the MSA concentration to 5 mM helped elute
GBA in less than 40 min. When the concentration of MSA was increased to more than 5 mM,
the first four compounds eluted with very close retention times and poor resolution. As is shown
in Figure 3, with 8 mM MSA, retention times were 4.3 (GAA), 4.96 (G), 5.73 (MG), and 6.56
(CRN) min. In general, analyte retention order is dictated by analyte charge, solvated volume,
and polarizability. In the case of these analytes, since they will all have the same charge at the
acidic pH of the eluent, the solvated volume is predicted to be the most dominant factor in
retention order.
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Figure 3 Effect of MSA concentration on the retention time of the guanidine compounds
with the GUA column. Conditions: flow rate 0.3 mL/min; MSA eluent, ambient
temperature, Au working electrode.

3.2.2. Two-step gradient elution in water
Separation of the five analytes (GAA, G, MG, CRN, GBA) was performed by a two-step
gradient on the GUA column at a flow rate of 0.3 mL/min. The best separation with the two-step
elution was achieved with 2 mM MSA for 20 min and 8 mM MSA for 20 min (Figure 4). This
approach has the potential for baseline separation of five analytes in water, with the order of
elution being GAA (6.88), G (7.88), MG (9.53), CRN (10.50) and GBA (24.88) min. Column
efficiencies calculated using peak widths and retention times for the two-step gradient elution are
good for IC separations as shown by the number of theoretical plates per meter in the 20,000
N/m range (Table 1) [48].
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Figure 4 Two-step gradient separation of uremic toxins with GUA column and PAD with
conventional working Au electrode. Peak assignment: 1-GAA, 2-G, 3-MG, 4-CRN, and 5GBA. Condition: flow rate 0.3 mL/min; eluents: 2 mM MSA for 20 min, 8 mM MSA for 20
min. Concentration for each analyte was 10 ppm. Peak resolutions (Rs): Rs1 = 1.66, Rs2 =
2.59, Rs3 = 1.29, Rs4 = 9.84.

3.2.3. Three-step gradient elution in water
A 3-step gradient was performed to improve the baseline separation between analytes.
The obtained order of elution was similar that with the 2-step gradient but with different
retention times and resolutions. The best separation was achieved with the following program: 1
mM MSA for 10 min, 2 mM MSA for 5 min, 15 mM MSA for 15 min. The resolution factors
were 5.6 (GAA-G), 3.7 (G-MG), 1.28 (MG-CRN) and 2.95 (CRN-GBA). Rinsing the column
with 2 mM MSA for 10 min before injecting the analytes was important to obtain a good
separation and reproducible retention times due to the rinsing protonating the ionic exchange
sites.
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The comparison of resolution factors between the 2- and 3-step gradients confirmed that
a 3-step gradient leads to a better separation (Table 1). The number of theoretical plates per
meter using the 3-step gradient was in the range of 20,000 to 100,000 N/m, which is more than
the separation with the 2-step gradient with concomitant improvement in resolutions between
peaks. The resolution between the first two peaks was much improved over the 2-step gradient.
Preference for one gradient over the other depends on the application and matrix composition.
3.2.4. Three-step gradient elution in urine
Synthetic urine contains several compounds such as urea, lactic acid, citric acid and
ammonium chloride, which could interfere with the detection of analytes. Indeed, several strong
peaks in a chromatogram arise due to these compounds. This difficulty was overcome using the
three-step gradient, which separated the five analytes effectively (Figure 5). The gradient was
composed of 3 mM MSA for 10 min, 5 mM MSA for 7 min, and 15 mM MSA for 13 min. The
order of elution (GAA, G, MG, CRN, and GBA) was the same as it was in water. Baseline
separation of the analytes was achieved even though the urine peaks were strong. With this
gradient program, the peak resolutions in most cases were even better than the gradient elution of
analytes in water. The number of theoretical plates per meter for the analytes ranged from 20,000
to 90,000 N/m, which lies within respectable values for IC (Table 1). The efficiency of the
column was confirmed by the separation of low concentrations of analytes. Concentrations of
500 and 250 ppb of analyte were detected in synthetic urine (Figure 6).
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Figure 5 Separation of uremic toxins in urine. Peak assignments: 1-GAA, 2-G, 3-MG, 4CRN, and 5-GBA (*urine peaks). Condition: flow rate 0.3 mL/min; gradient: 3 mM MSA
for 10 min, 5 mM MSA for 7 min, and 15 mM MSA for 13 min. Concentration for each
analyte was 4 ppm, except GBA which was 24 ppm. Peak resolutions (Rs): Rs1 = 3.70, Rs2
= 4.79, Rs3 = 4.28, Rs4 = 2.34.
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Figure 6 Separation of low concentrations of uremic toxins in urine. Peak assignments: 1GAA, 2-G, 3-MG, 4-CRN, and 5-GBA (*urine peaks). Condition: flow rate 0.3 mL/min;
gradient: 3 mM MSA for 10 min, 5 mM MSA for 7 min, and 15 mM MSA for 13 min.
Concentration for each analyte was 500 ppb for lower line and 250 ppb for upper line.
Peak resolutions for 500 ppb chromatogram (Rs): Rs1 = 3.86, Rs2 = 3.06, Rs3 = 1.20, Rs4 =
9.79.
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Table 1 Chromatographic results for the determination of uremic toxins by gradient
elutions with GUA column prepared by grinding.a
2-step gradient

Solutes

tR
(min)b

Peak
width
(min)

3-step gradient

Number
of plates
(N/m)

tR
(min)b

Peak
width
(min)

3-step gradient in urine

Number
of plates
(N/m)

tR
(min)b

Peak
width
(min)

Number of
plates
(N/m)

GAA

6.72

0.54

26000

8.43

0.71

23000

8.38

0.66

27000

G

7.65

0.58

29000

15.22

1.07

34000

14.12

0.72

64000

MG

9.17

0.59

40000

17.93

0.69

110000

17.13

0.72

94000

CRN

10.07

0.80

26000

19.02

0.94

68000

18.28

0.97

59000

GBA

24.88

2.27

20000

23.6

2.16

20000

26.38

2.26

23000

a. Conditions: 3 × 150 mm GUA column prepared by grinding, flow rate 0.3 mL/min, gradient
programs with MSA eluent, ambient temperature. b. retention time.

3.2.5 Real urine analysis
A real urine sample was filtered, diluted and passed through a guard column before
analysis. Due to the more complicated matrix, a 5-step gradient was necessary to achieve a
successful separation. Unspiked and spiked urine samples were compared and the unspiked
samples were found to contain creatinine (CRN), but not any of the other uremic toxins at levels
high enough to be detected (Figure 7). The creatinine concentration was 1.6 ppm in the urine.
Urine creatinine (24-hour sample) values can range from 500 to 2000 mg/day [2, 49]. The levels
of GAA, G, MG, and GBA in a healthy person are normally below 50 ppb [2] and thus were not
detected by our technique. The gradient was composed of 1 mM MSA for 10 min, 2 mM MSA
for 5 min, and 3 mM MSA for 5 min, 4 mM MSA for 5 min, 15 mM MSA for 5 min. Spiked

104

urine samples (950 ppb of analyte) resulted in sharp and well resolved peaks in the presence of
the complicated matrix.
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Time (min)

Figure 7 Identification of uremic toxins in real urine. Chromatograms: lower, analytes in
water; middle, urine; upper, spiked urine. Peak assignments: 1-GAA, 2-G, 3-MG, 4-CRN,
and 5-GBA; the urine components gave rise to the other peaks. Conditions: flow rate 0.3
mL/min; gradient: 1 mM MSA for 10 min, 2 mM MSA for 5 min, and 3 mM MSA for 5
min, 4 mM MSA for 5 min, 15 mM MSA for 5 min. Concentration of each analyte was 950
ppb in lower and upper chromatograms. Peak resolutions of uremic toxins in the spiked
urine chromatogram (Rs): Rs1 = 4.58, Rs2 = 3.91, Rs3 = 1.75, Rs4 = 8.22.

3.2.6. Integrated pulsed amperometric detection
IPAD provided a method to detect all of the analytes whether they did or did not have a
chromophoric group. This detection method in water and urine achieved good signal-to-noise
and measured detection limits in water were (ppb) 10 (GAA), 9 (G), 12 (MG), 40 (CRN), and 12
(GBA) (Table 2). These detection limits were achieved at room temperature with a 0.3 mL/min
flow rate. To confirm the reproducibility and sensitivity of the gold working electrode in the
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presence of high matrix concentrations, calibration curves were obtained for the analytes in
urine. The detection limits in urine turned out to be larger than those in water (Table 3);
however, all of the analyte detection limits were in the ppb range. The decrease in the sensitivity
of the detector to the analytes in urine is attributed to the interference at the electrode by the
urine components: citric acid, ammonia, and lactic acid. The disturbance caused by the urine
components was confirmed by injecting just urine. The detection limits for the column are within
the concentrations observed in uremic patients’ urine and serum, which lie in the range of 100 to
1800 ppb [2,4]. The low detection limits support the feasibility of using PAD for clinical
analysis of guanidine compounds.

Table 2 Calibration equations and LODs for analytes at ambient temperature.a
Analytes

Linear equation

Correlation
coefficient

Concentration
range (ppm)

LOD
(ppb)b

LOQ
(ppb)c

GAA

y = 4.473x + 9.434

0.916

0.1-10

10

33

G

y = 8.716x + 17.45

0.953

0.1-10

10

30

MG

y = 6.761x + 11.19

0.919

0.1-10

12

41

CRN

y = 7.042x + 22.39

0.921

0.1-10

47

160

GBA

y = 5.166x + 0.949

0.999

0.1-10

12

41

a. Conditions: 3 x 150 mm GUA column prepared by grinding, Au conventional working electrode,
flow rate 0.3 mL/min, MSA eluent, and ambient temperature.
b. limit of detection (LOD) which was calculated according to the formula LOD = 3.3(SD/S).
c. limit of quantification (LOQ) which was calculated according to the formula LOQ = 10(SD/S).
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Table 3 Calibration equations and LODs for analytes in urine at ambient temperature.a
Analytes

Linear equation

Correlation
coefficient

Concentration
range (ppm)

LOD
(ppb)b

LOQ
(ppb)c

GAA

y = 1.016x + 25.87

0.9373

2-60

92

307

G

y = 1.528x + 32.67

0.9631

2-60

28

93

MG

y = 1.110x + 4.405

0.985

2-60

95

319

CRN

y = 1.401x + 15.77

0.9881

2-60

175

591

GBA

y = 4.34x + 28.01

0.9256

2-60

146

487

a. Conditions: 3 x 150 mm GUA column prepared by grinding, Au conventional working electrode,
flow rate 0.3 mL/min, MSA eluent, and ambient temperature.
b. limit of detection (LOD) which was calculated according to the formula LOD = 3.3(SD/S).
c. limit of quantification (LOQ) which was calculated according to the formula LOQ = 10(SD/S).

3.2.7. Column robustness
The efficiency and performance of a column often decreases with use, and therefore the
columns were tested for stability. The robustness of the packed GUA column was verified by
eluting guanidine for 50 runs under isocratic conditions at 25 °C and an additional 50 runs at
elevated temperatures. These runs were performed under a flow rate of 0.3 mL/min with 4 mM
MSA. The peak areas were ± 1.73 nC and the retention times appeared between 5.57-5.60 min.
Retention times, peak areas, and peak shapes did not change significantly from the first to the
last run. Furthermore, continual use of the column over time resulted in consistent separations of
analytes.

4. Column characterization
The SEM images from the GUA coated resin before and after grinding show that a
significant amount of resin has been broken into smaller material (Figure 8). Grinding the resin is
important to break up the resin aggregates. This preparation method results in higher
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backpressures and slower separations. The slower separations were necessary to separate the
analytes from the urine matrix peaks.

Figure 8 SEM images of resin. Pictures: left, divinylbenzene macroporous resin coated with
GUA; right, resin coated with GUA and ground for 4 hours.

Column porosity and dynamic binding capacity affect column resolution and how
concentrated the eluent needs to be. The total porosity of the packed column was calculated
based on the void volume of the column and total volume of the empty column. The calculated
total porosity of the column was found to be 63%. The dynamic binding capacity was found by
using 25 mM GBA as eluent and noting a sharp increase in the baseline at 3.8 min. The total
measured dynamic binding capacity for the column was 12 mM/column base on the
breakthrough calculation. This high binding capacity of the column related to high surface area
available for coating with GUA, which apparently arises from small pieces of particles during
grinding.
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5. Conclusions
This research shows the potential for packing materials based on resorcinarenes for the
separation of uremic toxins in water and urine. Three and four step gradient elutions are
necessary to obtain good separation of the analytes from each other and matric components.
Even in the presence of urine matrix, uremic toxin concentrations were detected in the biological
relevant range (ppb) with the new columns using PAD. The 4.5 micron resin was found to be
crushed during preparation by grinding. The columns capacity for the 3 x 1500 mm column was
12 mM/column and the columns were stable over many runs. Ion chromatography, although used
less often, is well suited to separate guanidino compounds in urine.
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Chapter 4 A New Approach for Trace Analysis of Guanidine Compounds in
Surface Water with Resorcinarene-based Ion Chromatography Columns
Abstract 2
Trace levels of pharmaceuticals have been detected in surface water and may pose a
health risk to humans and other organisms. New chromatographic materials will help identify
and quantify these contaminants. We introduce a new ion chromatographic (IC) material
designed to separate cationic pharmaceuticals and report its ability to separate a group of
guanidine compounds. Guanidine moieties are strongly basic and protonated under acid
conditions, and therefore can potentially be separated on the newly designed stationary phase and
detected by ion exchange chromatography. The new column packing material is based on
glutamic acids bonded to resorcinarene moieties that in turn are bound to divinylbenzene
macroporous resin. Detection limits in the range of 5 - 32 μg L-1 were achieved using integrated
pulsed amperometric detection (IPAD) for guanidine (G), methylguanidine (MG), 1,1dimethylbiguanide (DMG), agmatine (AGM), guanidinobenzoic acid (GBA) and cimetidine
(CIM). Suppressed conductivity (CD) and UV-vis detection resulted in limits of detection similar
to IPAD, in the range of 1.7 - 66 μg L-1, but were not able to detect all of the analytes. Three
water sources, river, lake, and marsh, were analyzed and despite matrix effects, sensitivity for
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guanidine compounds was in the 100 μg L-1 range and apparent recoveries were 80-96 %. The
peak area precision was 0.01 - 2.89% for IPAD, CD and UV-vis detection.
Keywords: Pharmaceutical contaminants; Ion chromatography; Cavitands; Guanidine compounds

1. Introduction
Trace amounts of pharmaceuticals, such as hormones, antibiotics, painkillers, psychiatric
and cardiac medications have been detected in surface waters and even in drinking water.1-3
There might be no immediate effect of small amounts of these pharmaceuticals on humans, but
there is concern that long-term, low-level exposure could be harmful. Human exposure to these
contaminants is not the only problem; environmental aquatic species have been affected.2,4 For
example, although short-term cimetidine exposure levels of below 30 mg L-1 did not affect
freshwater fleas or zebrafish, long term exposure had a high potential for endocrine disruption.5
In a related study, it was found that small cimetidine concentrations (70 μg L-1) affected growth,
reproduction, and survivorship of invertebrates.6 These contaminants have been present in water
for a long time, but their concentration has only recently been quantified and considered
potentially hazardous to ecosystems. There is a need to achieve methods for detection and
quantification of these contaminants from different water sources.3,7-11
With its ability to detect small quantities of ions in aqueous solutions, ion
chromatography (IC), is well suited to quantify some pharmaceutical contaminants.12-15 One of
the most needed developments for applying IC to this problem is the production of new
stationary phases.16-21 These stationary phases must have functional groups that will selectively
bind and separate the contaminants. Macrocyclic compounds such as crown ethers, cryptands,
cyclodextrins and resorcinarenes have been introduced as effective IC exchangers in both
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stationary and mobile phases.22-26 The resorcinarenes are a recently developed class of
macrocyclic compounds used as ion exchangers and our previous research on resorcinarene
stationary phases confirms their usefulness as separators in IC systems.25,27-30 Synthesizing these
compounds with long alkyl chains facilitates their adherence to the packing resin. The upper rim
of the resorcinarene structure can be functionalized with carboxylic groups, which can act as ion
exchangers (Figure 1). The resorcinarene tetramer brings the carboxylic acid groups in close
proximity to work in a cooperative manner during analyte binding.
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Figure 1 Glutamic acid resorcinarene with undecyl groups (GUA).

We have designed a new stationary phase containing resorcinarene sites to be used to
separate a guanidine family of pharmaceutical contaminants.31,32 The group of interest includes:
guanidine (G), methylguanidine (MG), 1,1-dimethylbiguanide (DMG), agmatine (AGM),
guanidinobenzoic acid (GBA) and cimetidine (CIM) (Figure 2). These all have the guanidine
subunit in common, but vary in structure ranging from the very polar guanidine to the alkyl
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containing cimetidine. This range of structures provides the opportunity to test the range of
application of this new stationary phase. These guanidine compounds have antacid properties
due to their basicity and have a wide range of pharmaceutical applications. For example,
dimethylbiguanide is an oral antidiabetic drug, agmatine has been given as a dietary supplement
and guanidine benzoic acid has a biological role in the body’s guanidine cycle. Cimetidine is a
histamine H (2)-receptor antagonist that inhibits stomach acid production. The excretion of such
drugs to urine ultimately is the source of apparent contaminants in surface water. The EPA has
called such contaminants as cimetidine “contaminants of emerging concern” and investigation
into their detection and removal is underway.1-3,32,34
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Figure 2 Guanidine compounds: guanidine (G), methylguanidine (MG), 1,1dimethylbiguanide (DMG), agmatine (AGM), guanidine benzoic acid (GBA), cimetidine
(CIM).

Sensitive and selective methods to determine trace amounts of guanidine compounds and
others like them in the environment as well as in bio-fluids would help detect illness.35 Yet these
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compounds often suffer from the absence of chromophoric or flourophoric groups, which would
render them not detectable by photosensitive methods. Indeed, chromatography is the most
common analysis method due to established advantages over enzymatic and spectrochemical
methods.36 The use of derivatizing reagents in the form of post or pre- column reagents is a
common way of detecting these compounds, although derivatization has apparent limitations.37-39
The use of IC with suppressed conductivity, IPAD or UV-vis detection provides a relatively
simple and low-cost technique for identification and quantification of these analytes with direct
detection and no need for pre- or post-column derivatizing steps.35
In this manuscript we present research on a new stationary phase used to detect and
quantify guanidine compounds by IC. As far as we know, this is the first report of guanidine
compounds analyzed in surface waters using IC techniques. The new column packing material
contains resorcinarene-based molecules functionalized with glutamic acid groups (GUA, Figure
1). Isocratic and multi-step gradient elution with methylsulfonic acid (MSA) as eluent proved to
separate all of the guanidine compounds with good peak resolution. Even for lake, river and
marsh water, with matrix peaks introduced by these water sources, the limits of detection and
quantification were in the μg L-1 range. Three methods of detection, electrochemical (IPAD),
conductivity detection (CD), and UV-vis, were employed and IPAD was found to work best for
all of the compounds, although UV-vis was very sensitive for cimetidine. This direct detection of
low ppm amounts of guanidine contaminants in environmental waters with easy sample
preparation provides a simple yet reliable method for determination of these contaminants.
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2. Experimental
2.1 Reagents
All reagents, including methanesulfonic acid (MSA), 50% NaOH solution, and guanidine
compounds were analytical grade and obtained from commercial suppliers. All eluents and
standards were prepared using Milli-Q (MQ) water of 18 Megaohm/cm resistivity. A solution of
1 M sodium hydroxide was used as the post column additive for IPAD detection. GUA was
prepared by following the same procedure used to synthesize a similar compound.28 Thermo
Scientific (Sunnyvale, CA) provided the 4.6 μm particle size 55% cross-linked styrenedivinylbenzene polymeric macroporous resin.

2.2 GUA column preparation
Columns were prepared by the method described previously.27 For example, 0.050 g of
GUA and 1.5 g of resin were dispersed in 25 mL of methanol. The slurry was dried at room
temperature. The dry powder was grinded with a mortar and pestle for 4 hours while 30 mL of
deionized water was added slowly; the slurry was then packed into a 3 × 150 mm black PEEK
column at 60 oC and 4000 psi for 10-15 minutes. The columns were preconditioned with 1 mM
MSA for 10 min at a flow rate of 0.8 mL/min before using for separations. The column void
volume is 0.66 mL, with a void time of 2.2 min and a flow rate of 0.30 mL/min. Divinylbenzene
macroporous resin (surface area of 350 m2/g) was used for column preparation. Given the length
(3 nm) and width (1 nm) of the GUA molecule and the amount of the resin used for each column,
the resin could accommodate on its surface a maximum of 6.0 x 10-5 mol (0.117 g) of GUA.
Thus, there is more than sufficient surface area on the resin particles to accommodate all of the
GUA used, with less than half of the resin surface area occupied. Conductivity detection was
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preceded by treatment with a CSRS 4 mm suppressor. The operating condition was
AutoSuppression mode.

2.3 Analyte preparation
Guanidine stock solutions were prepared at 300 mg L-1 in deionized water and stored in
the refrigerators at 4 °C. The environmental water samples were collected from the Provo River,
Utah Lake and marsh water by Utah Lake and kept in plastic bottles in the refrigerator at 4 °C.
The environmental water was filtered through cellulose filter paper (pore size 0.015-12 µm) to
remove dirt and suspended particles and then centrifuged at 4000 rpm for 5 min. The centrifuged
water was filtered through a 0.25 µm mesh Thermo Scientific Nalgene syringe filter, which is a
surfactant-free cellulose acetate filter. Weak cation exchange solid phase extraction (WCX-SPE)
material was used to remove the anionic species from the water. The WCX-SPE was first washed
with deionized water under positive pressure airflow and then a 12 mL water sample was run
through the WCX-SPE without positive pressure. The analytes were collected from the WCXSPE by running 12 mL of 50 mM MSA through the WCX-SPE.
To determine the detectability of low levels of analytes, environmental water samples
were spiked with the guanidine compounds. The apparent recoveries were obtained using
calibration curves in the range of 0.05 - 0.8 mg L-1. River water samples were spiked with 12 mg
L-1 of analyte and 10 mL of water was filtered and loaded on SPE. The SPE was washed with 10
mL of 50 mM MSA, which was analyzed with an electrochemical detector. The apparent
recoveries were calculated with the equation R = (Xaexp/Xatheor) 100%, where R is recovery,
Xaexp is the value experimentally obtained and Xatheor is the known or theoretical value.40 The
apparent recoveries averaged over 4 times and relative standard deviations (RSD) were: G 96
(3.3), MG 90 (1.2), DMG 88 (0.2), AGM 85 (2.3), GBA 86 (2.2), and CIM 81 (1.1). To prepare
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the spiked water samples, a 100 mg L-1 stock solution of analytes was first diluted to 3.50 mg L1

, then to 600 μg L-1 or 300 μg L-1, and finally diluted with environmental water to 75 or 150 μg

L-1.

2.4 Instrumentation
The ICS-5000+ Ion Chromatography system (Thermo Scientific) was used in this work.
The system was equipped with a DP-5000+ gradient pump, a DC-5000 detector compartment
with conductivity cell and IPAD cell, and an ASAP automated sampler. The Chromeleon® 7
software was used for system control and data processing. The CERS 500 (4 mm) selfregenerating suppressor at 40 mA was used for suppressed conductivity detection. A 5 µL
sample injection volume was used throughout. Post-column addition of 1 M NaOH was
delivered to a mixing tee at a flow rate of 0.5-0.6 ml/min to increase the eluent pH for detection
by IPAD. A 125 µL knitted reaction coil was installed between the mixing tee and
electrochemical cell to insure enough time for sodium hydroxide to mix with analyte. The IPAD
cell consisted of a disposable Au working electrode, a titanium counter electrode, and a pHAg/AgCl combination reference electrode. The electrochemical waveform used for IPAD was
based off one previously used to detect biogenic amines.12 It was 0.13 V from 0.00 s to 0.04 s,
0.33 V from 0.05 s to 0.21 s, 0.55 V from 0.22 s to 0.46 s, 0.33 V from 0.47 s to 0.56 s, -1.67 V
from 0.57 s to 0.58 s, and 0.93 V from 0.59 s to 0.60 s. Data was collected at a frequency of 1.67
Hz for IPAD and 5 Hz for the conductivity detector.
A PDA UV–vis detector with a combined deuterium/tungsten lamp and 10 mm cell was
attached to the column outlet and placed in line with suppressed conductivity detector. The
optimum detection wavelength was 200 nm, which most of the guanidine compounds showed the
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highest sensitivity. The IPAD set-up was a little different since it required a post column reagent
to provide a basic solution for the Au electrode.

2.5 Limits of detection and precision
To obtain the linear range of guanidine compounds for IPAD, suppressed conductivity
and UV-vis detectors, the correlation between peak area and concentration was identified. Two
sets of calibration curves were prepared for each of the guanidine analytes in deionized water
using five increasing concentrations in the range of 0.10 - 20 and 0.05 - 0.80 mg L-1. The
analytes were measured separately three times. The limits of detection (LODs) and limits of
quantification (LOQs) were calculated for each detector based on the slopes of the calibration
curves using the equation LOD = 3.3(SD/S) and LOQ = 10(SD/S), where SD is the standard
deviation and S is the slope of the line of the calibration equation. Replicate injections of
solutions containing G (8.3 ppm), MG (8.3 ppm), CIM (8.3 ppm), of DMG (16.6 ppm), AGM
(16.6 ppm) and GBA (16.6 ppm) were performed to measure retention times and peak area
precisions. The replicate injection precisions were evaluated for IPAD, CD, and UV-vis
detection by performing 4 consecutive injections of each analyte.

3. Results and discussion
3.1 Separators
The eight carboxylic acid groups from each GUA are positioned around one face of a
resorcinarene (Figure 1). These carboxylic acid groups provide hydrogen bonding sites at low pH
and anionic binding sites at neutral and high pH, while the benzyl groups of the cavitand provide
for nonpolar interactions. The long alkyl groups on the lower rim of the cavitands are for
absorption of the cavitands to the polystyrene column packing material. IR investigation of the
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packing material showed a peak at 1700 cm-1correlating to the carboxylic acid group of the
resorcinarene, which was not present in pure resin. SEM characterization of the material showed
that some of the 4.6 μm beads had been crushed during the grinding process.27 Total porosity of
the GUA column was 63% and the dynamic binding capacity of the packed column was 12
mM/column for GBA.

3.2 Isocratic elution in water
Separation of the guanidine compounds (G, MG, DMG, AGM, GBA, CIM) with the
GUA column was first attempted by isocratic elution using 1, 2, 3, 4, 5.5, 6, 8, and 10 mM MSA
and a flow rate of 0.8 mL/min. The compound retention times (min) with 1 mM MSA were 2.27
(G), 2.87 (MG), 9.37 (DMG), and 18.37 (AGM). GBA and CIM did not elute from the column
with 1 mM MSA (Figure 3). Increasing the concentration of MSA to 2 mM led to reduced
retention times (min) of 1.67 (G), 1.97 (MG), 4.32 (DMG), 5.55 (AGM) and elution of GBA at
11.4 min. It took 6 mM MSA to elute CIM in 35 min., but at this and higher MSA
concentrations, the first four analytes began to coelute.
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Figure 3 Effect of MSA concentration on the retention time of the guanidine compounds
with the GUA column.

The order of analyte elution can be attributed to the analyte charge, solvated volume,
size, and presence of hydrophobic groups. Guanidine has the highest charge density of the
analytes, and thus maintains its hydration sphere, resulting in less attraction to the column active
sites and a shorter retention time. Compared to guanidine, methyl guanidine and
dimethylbiguanide are larger and have alkyl groups, which results in them having slower mass
transfer than guanidine and longer retention times. Agmatine is dicationic in solution, is larger in
size and has alkyl groups, features which lengthen its retention time. Guanidine benzoic acid, has
a phenyl group, which results in slower mass transfer and a longer retention time. Cimetidine, the
largest and most hydrophobic member of the group, eluted last due to slow mass transfer rate and
stronger absorption to the hydrophobic polystyrene resin.
We have observed by NMR that the carboxylate groups of a similar resorcinarene
interacted with the amine groups of various benzyl amines.28 We also observed that the
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resorcinarene more strongly bound amine than did the monomeric analog. Thus, for GUA the
carboxylic acid groups are proposed to be the sites of interaction with the analytes and
specifically the guanidine groups of the analytes. With another resorcinarene, this one containing
four cyclen groups attached to the upper rim of the resorcinarene, we observed that the
resorcinarene efficiently separate anions while a compound with a single cyclen did not.41 We
propose the carboxylic acids of GUA are also working in a cooperative manner to bind analytes

3.3 Gradient elution with MSA in water
Multi-step gradient elution resulted in the best resolution of the analytes in the shortest
time (Figure 4). The best separation was achieved with a flow rate of 0.8 mL/min using 1 mM
MSA for 5 min, 2 mM for 5 min, 3 mM for 5 min, and 25 mM for 30 min. The elution order was
the same as that found in the isocratic runs and the conditions with IPAD were a little different
than the other two detection methods due to the post column reagent system. The peak resolution
factors for the peak pairs in this order were 1.3, 5.5, 1.0, 1.4, and 6.6 using IPAD. The presence
of MSA as eluent in high concentrations caused an increase in baseline, attributed to the trace
electrocatalytic activity of MSA on the surface of gold working electrode. As seen in Table 1, the
chromatographic parameters for the separation of guanidine compounds on the GUA column
gave plate numbers from 3 to 10 thousand N/m. Replicate injections of solutions containing 8.3
mg L-1 of G, MG, and CIM, and 16.6 mg L-1 of DMG, AGM and GBA were performed to
measure retention times and peak area precisions. RSDs for the retention time and peak area of
the replicate injections with multi-step gradient elution of MSA and IPAD were 4.29 and 4.30%,
respectively.
Without GUA on the packing material and under the same conditions, no retention was
seen for G, MG, DMG, and AGM. GBA was slightly retained and CIM was significant retained,
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coming off at 24 min. Thus, GUA is critical for analyte separation, but as seen with CIM
retention, the hydrophobic resin also plays a role in retention. The GUA molecules create cation
exchange sites, which work in conjunction with the hydrophobic resin to allow analyte
separation under low concentrations of MSA.
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Figure 4 Separation of guanidine compounds with GUA column and IPAD. Peak
assignment: 1-G, 2-MG, 3-DMG, 4-Agm, 5-GBA, 6-Cim. Conditions: flow rate 0.8 ml/min.
Gradient, 1mM MSA for 5 min, 2 mM for 5 min, 3 mM for 5 min, 25 mM for 30 min.
Analyte concentrations (mg L-1): G and MG (8.3); DMG, AGM and GBA (16.6); CIM (8.3).
Peak resolutions (Rs): Rs1 = 1.3, Rs2 = 5.5, Rs3 = 1.0, Rs4 = 1.42, Rs5 = 6.6.
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Table 1 Chromatographic parameters for the determination of guanidine compounds by
step gradient ion chromatography with GUA columns
IPAD

CD

UV

tR (min)

Halfpeak
width
(min)

Plates
number
(N/m)

20000

8.4

0.33

33000

0.51

16000

9.5

0.46

19000

21.3

0.85

26000

22.7

1.33

13000

3000

23.3

1.49

11000

-

-

-

1.26

5000

27.2

1.95

8000

27.4

1.48

15000

2.07

10000

-

-

-

50.6

1.9

30000

Analyte

tR
(min)

Half-peak
width
(min)

Plates
number
(N/m)

G

2.3

0.27

MG

2.9

DMG

tR (min)

Half-peak
width
(min)

Plates
number
(N/m)

4000

8.7

0.403

0.29

6000

9.9

8.1

0.82

4000

AGM

9.8

1.2

GBA

13.3

CIM

31.8

Conductivity detection is one of the most commonly available detection methods in
analyzing ionic water contaminants and was also investigated as a possible detection method in
this work. The use of modest amounts of MSA and no organic solvent allowed us to use
conductivity suppressed detector. The cation suppressor led to low noise levels and improved the
methods’ sensitivity for guanidine compounds in the acidic solvent. Five of the six guanidine
compounds were detected, but cimetidine was not (Figure 5). The separation was carried out at
flow rate 0.5 mL/min and the best applied multi-step gradient was 1mM MSA for 5 min, 2 mM
for 5 min, 3 mM for 5 min, 4 mM for 5 min, 5 mM for 5 min, 6 mM for 5 min, and 25 mM for
20 min. The chromatographic parameters for the separation of guanidine compounds on the
GUA column with this gradient gave plate numbers greater than electrochemical detection and
from 32 to 105 hundred thousand N/m (Table 1). The peak resolution factors were good at 1.6,
9.9, 1.0, and 1.2. The calculated RSDs for the retention times and peak areas of the replicate
injections with suppressed conductivity detection were 2.39 and 2.20 %, respectively.
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Figure 5 Separation of guanidine compounds with GUA column and CD. Peak
assignments: 1-G, 2-MG, 3-DMG, 4-Agm, 5-GBA. Conditions: flow rate 0.5 ml/min.
Gradient:1mM MSA for 5 min, 2 mM for 5 min, 3 mM for 5 min, 4 mM for 5 min, 5 mM
for 5 min, 6 mM for 5 min, 25 mM for 20 min. Analyte concentration (mg L-1): G and MG
(8.3); DMG, AGM, GBA and CIM (16.6). Peak resolutions (Rs): Rs1 = 1.6, Rs2 = 9.9, Rs3 =
1.0, Rs4 = 1.2.

UV-vis detection is the most universal detection method in chromatography systems and
was also used with the guanidine compounds in this work. A short wavelength of 200 nm was
used to excite the guanidine compounds in an attempt to detect as many compounds as possible.
Five of the six compounds were detected by UV-vis (the exception was agmatine) and one of the
five (guanidine) was very weak (Figure 6). Agmatine does not absorb at 200 nm and was thus
not detected. The separation flow rate was 0.5 mL/min and the gradient elution was the same as
suppressed conductivity separation. The obtained peak resolution factors were 1.7, 13.3, 2.0, and
8.1. The chromatographic parameters gave plate numbers from 13 to 30 hundred thousand N/m
and especially high for cimetidine (Table 1). Replicate injections were performed to measure
retention times and peak area precisions. The obtained RSDs for the retention times and peak
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areas with gradient elution of MSA and UV-vis was 3.21 and 2.21%, respectively. The RSDs
were low for all of the detection methods.
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Figure 6 Separation of guanidine compounds with GUA column and UV-vis detection.
Peak assignments: 1-G, 2-MG, 3-DMG, 5-GBA, 6-CIM. Conditions: flow rate 0.5 ml/min.
Gradient: 1mM MSA for 5 min, 2 mM for 5 min, 3 mM for 5 min, 4 mM for 5 min, 5 mM
for 5 min, 6 mM for 5 min, 25 mM for 20 min. Initial concentrations (mg L-1): G and MG
(8.3); DMG, AGM, GBA and CIM (16.6). Peak resolutions (Rs): Rs1 = 1.7, Rs2 = 13.3, Rs3
= 2.0, Rs4 = 8.1.

Limits of detection and quantification were calculated for each detection method and
found to be very good and in the μg L-1 range (Table 2). The limits of detection were the smallest
for electrochemical detection and ranged from 6–32 μg L-1 for G, MG, DMG, AGM, and CIM.
The detection limit for GBA was a little greater at 76 μg L-1. The limits of detection for
conductivity were a little lower in the 1.7 to 8.2 μg L-1 range, except for CIM which couldn’t be
detectable with CD. UV-vis detection proved to be very good for cimetidine (5.1 μg L-1), while
it was comparable to the other methods for the other analytes, except, as stated before, for
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arginine and guanidine. Comparing the three methods, IPAD was the best for detecting all six of
the analytes due to the guanidine subunit being able to be oxidized on the gold electrode with the
correct applied waveform and basic conditions provided by sodium hydroxide through the post
column reactor.

Table 2 Limits of detection (LOD) and quantification (LOQ) of guanidine compounds with
IPAD, CD and UV-vis detection at room temperature with MSA
Analyte

IPAD

CD

UV-vis

LOD
(μg L-1)

LOQ
(μg L-1)

LOD
(μg L-1)

LOQ
(μg L-1)

LOD
(μg L-1)

LOQ
(μg L-1)

G

6

20

1.7

5.7

66

220

MG

5.0

17

8.2

27

24

82

DMG

32

110

15

52

11

34

AGM

8.6

29

1.7

5.7

ND

ND

GBA

76

250

5.7

19

34

110

CIM

8.3

28

ND

ND

5.1

17

ND, not detected.

3.4 Analysis of guanidine compounds in river, lake and marsh water
After noting the efficient separation of the guanidine compounds in pure water with the
GUA column, we evaluated the application of the technique to surface water sources, i.e. river,
lake and marsh. The presence of organic and bioorganic compounds, such as humic substances
and a variety of minerals makes natural water sources a complicated matrix to detect and separate
very small concentrations of the pharmaceutical analyte.
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None of the analytes was detected in the sampled river water under gradient conditions,
although there were large matrix peaks (Figure 7). However, low levels of the analytes were
detected when river water was spiked with 75 μg L-1 of each analyte and the multi-step gradient
was composed of 1 mM MSA for 5 min, 2 mM for 5 min, 3 mM for 5 min, 4 mM for 5 min, 5
mM for 5 min, 6 mM for 5 min, 7 mM for 5 min, 8 mM for 5 min, and 25 mM for 20 min
(Figure 7). Due to matrix peaks the run conditions and gradient were different from those used
with pure water. Since electrochemical detection was able to detect all 6 guanidine compounds in
water, we chose this detection method to analyze the surface water samples. The elution order of
the analytes was the same as it was in pure water. The apparent recoveries of the analytes
through the SPE filtration were high and ranged from 80 to 96%. The G was the highest and the
CIM was the lowest due to their hydrophobic nature and retention on SPE.
As shown by the chromatograms, the matrix compounds affect analyte resolution. The
chromatograms show three prominent matrix peaks at 2.5, 16 and 19 minutes in all of the water
sources. The major ions in these water sources are: HCO3- (260 mg/L), SO42- (40 mg/L)-, Cl- (15
mg/L), Ca2+ (55 mg/L), Mg2+ (15 mg/L), K+ (3 mg/L), and Na+ (10 mg/L) 42 and the biochemical
oxygen demand BOD5 equals 0.28 – 0.5 mg/L.43 The major anions in the waters would not be
appreciably retained on the column and indeed we saw that Cl- and SO4-2 eluted from the column
at the same time as the first matrix peaks. Thus, we propose the matrix peak at 2.5 min is due to
anions. The use of SPE significantly improved the signal to noise ratio due to the elimination of
anionic species. The main cations in the water sources would be retained on the column, elute
with the analytes, and could cause analyte separation problems. Under the IPAD conditions used,
the reduction of the cations in this list is not feasible, since they have more negative reduction
potentials than the applied electrode potential of -1.67 to + 0.55 V. Although the cations might
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affect baseline noise, they do not give rise to the matrix peaks we observe. The compounds
responsible for the matrix peaks at 16 and 19 minutes are being retained on the column and elute
with the organic-based analytes. Therefore, it is likely that these matrix peaks are due to organicbased cations, maybe even ones that contain amine groups.
After noting the ability of the GUA column to separate low concentrations of analytes, a
comparison between it and a commercial column was made. All six analytes were detected using
the Dionex IonPac CS-17 analytical column (Figure 24, appendix), however there were
differences. The biggest difference in the chromatograms was the baseline noise increased due to
the greater MSA concentrations required to remove the analytes from the commercial column. A
second difference was the signal from GBA was weaker and broader. Also, although the peak for
MG was still weak, it now came close to the matrix peaks.
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Figure 7 Separation of guanidine compounds in river water with GUA column and IPAD.
Peak assignments: 1-G, 2-MG, 3-DMG, 4-Agm, 5-GBA and 6- CIM. Conditions: flow rate
0.6 ml/min. Gradient: 1mM MSA for 5 min, 2 mM for 5 min, 3 mM for 5 min, 4 mM for 5
min, 5 mM for 5 min, 6 mM for 5 min, 7 mM for 5 min, 8 mM for 5 min, 25 mM for 20
min. Analyte concentrations equal 75 μg L-1.
Lake water samples had similar matrix peaks to river water and were also void of the 6
guanidine analytes. Using the same gradient as for river water, the low levels of analytes (150 μg
L-1) were able to be separated in spiked samples of lake water even with the presence of matrix
peaks (Figure 8). The detectable levels of analytes are a little higher than they were for river
water due to the stronger matrix peaks in these sources. The elution order was the same as it was
for river water samples and ppb levels of analyte were detected. As with the river water, the lake
water was filtered before being introduced into the instrument.
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Figure 8 Separation of guanidine compounds in lake water with GUA column and IPAD.
Peak assignments: 1-G, 2-MG, 3-DMG, 4-Agm, 5-GBA and 6-CIM. Conditions: flow rate
0.6 ml/min. Gradient: 1mM MSA for 5 min, 2 mM for 5 min, 3 mM for 5 min, 4 mM for 5
min, 5 mM for 5 min, 6 mM for 5 min, 7 mM for 5 min, 8 mM for 5 min, 25 mM for 20
min. Analyte concentrations equal 150 μg L-1.
The marsh water showed a similar set of matrix peaks and was also not contaminated
with any of the guanidine compounds. Low levels (μg L-1) of the six guanidine compounds were
detected and quantified in spiked marsh water samples using the same flow rate and gradient
elution of MSA (Figure 9). The GUA column is able to separate the analytes in the marsh water
even with the presences of matrix ions that come with the water.
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Figure 9 Separation of guanidine compounds in marsh water with GUA column and IPAD.
Peak assignments: 1-G, 2-MG, 3-DMG, 4-Agm, 5-GBA and 6- CIM. Conditions: flow rate
0.6 ml/min. Gradient: 1mM MSA for 5 min, 2 mM for 5 min, 3 mM for 5 min, 4 mM for 5
min, 5 mM for 5 min, 6 mM for 5 min, 7 mM for 5 min, 8 mM for 5 min, 25 mM for 20
min. Analyte concentrations equal 150 μg L-1.

4. Conclusions
The new GUA solid phase material effectively separated six different guanidinecontaining compounds in pure water samples. Multi-step gradient elution with MSA was
required to obtain good separations of analytes and matrix ions on the GUA column. Detection
was found to be practical with IPAD, CD and UV-vis detection, with IPAD best in terms of the
number of analytes detected. The new column material also effectively separated low levels of
analytes in different environmental water sources, including river, lake, and marsh. The
quantification of these analytes in the μg L-1 range by this IC method, means this method is as
good or better than other chromatography and mass spectrometry methods.44,45 However, with
simple sample preparation, this IC method has advantages over other methods. The GUA
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packing material used in IC systems gives a new option to separate pharmaceuticals and will lead
to further research on other resorcinarene compounds with the potential for greater selectivity.
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Chapter 5 Conclusion and Perspective
Deep chiral cavitands were synthesized and characterized with different techniques and
have the tetramer structure of the cavitand. Glutamic ester and acid cavitands were fully
characterized with NMR, mass spectroscopy, DLS, SEM, and TEM techniques. A series of
amine guests with different substituent groups were used to analyze the binding strength and
chiral recognition of GMA in DMSO. The comparison of binding constant between GMA and
PGA showed the importance of tetramer structure in enhancing the binding strength between
amines and host molecules. The greatest chiral discrimination was observed for secondary
amines. DLS analysis showed the presence of agglomeration for ester and acid derivatives. The
stimuli for reducing agglomerations were found to be concentration, pH, and temperature.
In addition, GUA was adsorbed onto 55% cross-linked styrene-divinylbenzene resin to
prepare new stationary phases for ion chromatography (IC) columns. These new IC columns
successfully separated uremic toxins in water and urine. Three and four step gradient elutions
were necessary to obtain good separation of the analytes from each other and matric components.
Even in the presence of urine matrix, uremic toxin concentrations were detected in the biological
relevant range (ppb) with the new columns using PAD. The newly designed IC columns also
effectively separated six different guanidine-containing compounds in pure water samples.
Detection was found to be practical with IPAD, CD and UV-vis detection, with IPAD best in
terms of the number of analytes detected. The new column material also effectively separated
low levels of analytes in different environmental water sources, including river, lake, and marsh.
Based on the experimental results that I have obtained, I propose several future research
projects which build on these results:
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1. The GUE ligand showed a vase-like structure with well-defined 1H NMR spectra in d6benzene. A hydrophobic pocket with a chiral opening can create asymmetric resorcinarenebased cavitands for chiral discrimination. The GUE ligand should be investigated more as
asymmetric carrier for small chiral molecules.
2. As mentioned, the self-assembly feature of the resorcinarene molecules can result in them
forming aggregates and several factors affect this process including concentration, pH, and
temperature. The self-assembly and pH-responsive behavior of GUA can efficiently
encapsulate drugs and release it. This is an area which can be widely used in drug delivery
systems and needs more investigation.
3. Another class of cavitands which has been recently designed and synthesized in our group, is
pillararenes. This class of cavitand can be modified with various substituents on their upper
and lower rims to provide specific functionality and selectivity. Recent studies show the great
potential of pillararenes in host-guest interactions.1–3 The adsorbance of pillararene
derivatives onto styrene-divinylbenzene resin can introduce new stationary phases to ion
chromatography columns.
4. The presence of chiral moieties in the GUA column provides stereoselectivity for chiral
analytes. Therefore, more investigation is required for achieving a chiral separation on the
GUA column.
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Chapter 6 Appendix
1. Characterization of Dimethyl 2-(2,3-dichloro-5,7-dioxo-5,7-dihydro-6Hpyrrolo[3,4-b]pyrazin-6-yl)pentanedioate (GPy)
3b
H

5

H3COOC

4

3a
1
H
COOCH3
2

N
O

O
N

N

Cl

Cl

Figure 1 The structure of GPy

Figure 2 1H NMR of GPy in CDCl3.
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Figure 3 13C NMR of GPy in CDCl3.

Figure 4 COSY NMR of GPy in CDCl3.
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2. Characterization of GME and GMA
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Figure 5 Structure of GME.

Figure 6 1H NMR of GME in d6-DMSO.
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Figure 7 13C NMR of GME in d6-DMSO.

Figure 8 COSY NMR of GME in d6-DMSO.
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Figure 9 HRMS (ESI) of GME, calculated for [M + H2O + H]+ 1775.5350, found 1775.4465 in
acetone.

Figure 10 HRMS (MALDI) of GME, for [M + Na]+ 1779.3935, found 1779.2547.
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Figure 11 Structure of GMA.

Figure 12 1H NMR of GMA in d6-DMSO.
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Figure 13 COSY NMR of GMA in d6-DMSO.

Figure 14 HRMS (ESI) of GMA calculated for [M + 9H2O + H]+ 1806.3877, found 1806.3717.
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3. Characterization of GUE and GUA
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Figure 15 Structure of GUE.

Figure 16 1H NMR of GUE in d6-C6H6.
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Figure 17 13C NMR of GUE in d6-C6H6.

Figure 18 COSY NMR of GUE in d6-C6H6.
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Figure 19 HRMS (MALDI) of GUE calculated for [M + Na]+ 2340.0215, found 2340.8124.
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Figure 20 Structure of GUA.

150

Figure 21 1H NMR of GUA in d6-DMSO.

Figure 22 COSY NMR of GUA in d6-DMSO.
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Figure 23 HRMS (ESI) of GUA calculated for [M + 9H2O + H]+ 2368.0055, found 2368.0144.
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spiked river water
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Figure 24 Separation of guanidine derivatives in river water. Peak assignments:1-G, 2-MG,
3-DMG, 4-Agm, 5-GBA and 6- CIM (* matrix peaks). Dionex IonPac CS17 analytical
column (4 x 250 mm) and IPAD were used. Conditions: flow rate 0.6 ml/min, column
equilibrated 10 min with 3 mM MSA before injection. 0-3 min 3mM MSA, 3-5 min 5 mM,
5-7min 7 mM, 7-9 min 9 mM, 9-11 min 10 mM, 11-13 min 11 mM, 13-15 min 13 mM, 15-17
min 14 mM, 17-19 min 15 mM, 19-21 min 17 mM, 21-23 min 19 mM, 23-30 min 20 mM, 3040 min 22 mM, 40-70 min 25 mM. Analyte concentrations equal to 75 µg/L.
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Table 3 Calibration curves data obtained with ED detection at room temperature with
MSA.

Concentration range 1-20 mg/L

Concentration range 0.05-0.85 mg/L

Analyte

Linear equation

R2

Linear equation

R2

LOD
(µg/L)

LOQ
(µg/L)

G

y = 0.248x - 0.132

0.99

y = 2.00×10-4x + 0.00340

0.99

1.7

5.7

MG

y = 0.196x - 0.0697

0.99

y = 2.00×10-4x - 0.00170

0.99

8.2

27

DMG

y = 0.125x + 0.0005

0.99

y = 8.00×10 x + 0.0299

0.99

15

52

AGM

y = 0.212x - 0.0419

0.99

-4

y = 1.00×10 x + 0.00360

0.99

1.7

5.7

GBA

y = 0.0931x - 0.00740

0.99

y = 8.00×10 x + 0.000300

0.98

5.7

19

-5

-5

a: relative standard deviation was obtained for 3 replications of each experiment
Table 4 Calibration curves data obtained with CD detection at room temperature with
MSA.

Concentration range 1-20 mg/L

Concentration range 0.05-0.85 mg/L

Analyte

Linear equation

R2

Linear equation

R2

LOD
(µg/L)

LOQ
(µg/L)

G

y = 0.248x - 0.132

0.99

y = 2.00×10-4x + 0.00340

0.99

1.7

5.7

MG

y = 0.196x - 0.0697

0.99

-4

y = 2.00×10 x - 0.00170

0.99

8.2

27

DMG

y = 0.125x + 0.0005

0.99

y = 8.00×10-5x + 0.0299

0.99

15

52

AGM

y = 0.212x - 0.0419

0.99

-4

y = 1.00×10 x + 0.00360

0.99

1.7

5.7

GBA

y = 0.0931x - 0.00740

0.99

y = 8.00×10 x + 0.000300

0.98

5.7

19

-5

a: relative standard deviation was obtained for 3 replications of each experiment
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Table 5 Calibration curves data obtained with UV-Vis detection at room temperature with
MSA.

Concentration range 1-20 mg/L

Concentration range 0.05-0.85 mg/L

Analyte

Linear equation

R2

Linear equation

R2

LOD
(µg/L)

LOQ
(µg/L)

G

y = 0.233x - 0.00260

0.99

y = 2.00×10-4x + 0.0122

0.99

66

220

MG

y = 1.03x - 0.949

0.99

y = 2×10-4x + 0.00930

0.99

24

82

DMG

y = 0.122x + 0.0366

0.99

y = 9.00×10 x + 0.0358

0.99

11

34

GBA

y = 0.0912x - 0.0341

0.99

-5

y = 9.00×10 x - 0.00460

0.98

34

110

CIM

y = 2.29x + 3.15

0.99

y = 758×10-4x + 4.69

0.98

5.1

17

-5

a: relative standard deviation was obtained for 3 replications of each experiment
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